US20200271629A1 - Coated flow path components for chromatographic effects - Google Patents
Coated flow path components for chromatographic effects Download PDFInfo
- Publication number
- US20200271629A1 US20200271629A1 US16/800,454 US202016800454A US2020271629A1 US 20200271629 A1 US20200271629 A1 US 20200271629A1 US 202016800454 A US202016800454 A US 202016800454A US 2020271629 A1 US2020271629 A1 US 2020271629A1
- Authority
- US
- United States
- Prior art keywords
- sample
- coating
- flow path
- modifier
- chromatographic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000694 effects Effects 0.000 title description 16
- 238000000576 coating method Methods 0.000 claims abstract description 190
- 239000011248 coating agent Substances 0.000 claims abstract description 160
- 238000000034 method Methods 0.000 claims abstract description 60
- 239000012491 analyte Substances 0.000 claims abstract description 53
- 230000003993 interaction Effects 0.000 claims abstract description 40
- 238000000926 separation method Methods 0.000 claims abstract description 26
- 230000005526 G1 to G0 transition Effects 0.000 claims abstract description 25
- 239000000463 material Substances 0.000 claims abstract description 22
- 230000014759 maintenance of location Effects 0.000 claims abstract description 14
- 230000007246 mechanism Effects 0.000 claims abstract description 13
- 238000000638 solvent extraction Methods 0.000 claims description 9
- 238000007740 vapor deposition Methods 0.000 claims description 8
- 238000005342 ion exchange Methods 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 abstract description 44
- 239000003607 modifier Substances 0.000 description 150
- 125000005103 alkyl silyl group Chemical group 0.000 description 65
- 239000012071 phase Substances 0.000 description 47
- 239000002738 chelating agent Substances 0.000 description 31
- 108090000765 processed proteins & peptides Proteins 0.000 description 31
- 150000003983 crown ethers Chemical class 0.000 description 30
- 102000004169 proteins and genes Human genes 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 24
- 239000012530 fluid Substances 0.000 description 23
- 238000005516 engineering process Methods 0.000 description 22
- 125000005843 halogen group Chemical group 0.000 description 21
- 229910052751 metal Inorganic materials 0.000 description 21
- 239000002184 metal Substances 0.000 description 21
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 20
- -1 glycans Proteins 0.000 description 19
- 102000004196 processed proteins & peptides Human genes 0.000 description 19
- 238000004811 liquid chromatography Methods 0.000 description 18
- 125000003545 alkoxy group Chemical group 0.000 description 16
- 150000002500 ions Chemical class 0.000 description 15
- 239000002253 acid Substances 0.000 description 13
- 150000001449 anionic compounds Chemical class 0.000 description 13
- 239000004094 surface-active agent Substances 0.000 description 13
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 150000007513 acids Chemical class 0.000 description 11
- 230000003385 bacteriostatic effect Effects 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- 108091034117 Oligonucleotide Proteins 0.000 description 10
- 230000002209 hydrophobic effect Effects 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 125000005037 alkyl phenyl group Chemical group 0.000 description 9
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 9
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 8
- CHXMKMLBOUWZFB-UHFFFAOYSA-N C[Si](C)(C)[Y][Si](C)(C)C Chemical compound C[Si](C)(C)[Y][Si](C)(C)C CHXMKMLBOUWZFB-UHFFFAOYSA-N 0.000 description 8
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 238000004891 communication Methods 0.000 description 8
- 239000003623 enhancer Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- WDVUXWDZTPZIIE-UHFFFAOYSA-N trichloro(2-trichlorosilylethyl)silane Chemical compound Cl[Si](Cl)(Cl)CC[Si](Cl)(Cl)Cl WDVUXWDZTPZIIE-UHFFFAOYSA-N 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000013375 chromatographic separation Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- 108060003951 Immunoglobulin Proteins 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 102000018358 immunoglobulin Human genes 0.000 description 6
- 239000003446 ligand Substances 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 241000894007 species Species 0.000 description 6
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 6
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 5
- 239000004696 Poly ether ether ketone Substances 0.000 description 5
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical group [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 238000002013 hydrophilic interaction chromatography Methods 0.000 description 5
- 229910021645 metal ion Inorganic materials 0.000 description 5
- 229920002530 polyetherether ketone Polymers 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 238000002444 silanisation Methods 0.000 description 5
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 5
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 4
- DMKCEJPDZDUPDV-UHFFFAOYSA-N C[Si](C)(C)CC[Si](C)(C)C Chemical compound C[Si](C)(C)CC[Si](C)(C)C DMKCEJPDZDUPDV-UHFFFAOYSA-N 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 4
- 239000005977 Ethylene Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000000148 multi-dimensional chromatography Methods 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- 230000002028 premature Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- NLMDJJTUQPXZFG-UHFFFAOYSA-N 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane Chemical compound C1COCCOCCNCCOCCOCCN1 NLMDJJTUQPXZFG-UHFFFAOYSA-N 0.000 description 3
- XQQZRZQVBFHBHL-UHFFFAOYSA-N 12-crown-4 Chemical compound C1COCCOCCOCCO1 XQQZRZQVBFHBHL-UHFFFAOYSA-N 0.000 description 3
- VFTFKUDGYRBSAL-UHFFFAOYSA-N 15-crown-5 Chemical compound C1COCCOCCOCCOCCO1 VFTFKUDGYRBSAL-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WTZBVIIGQDJARG-UHFFFAOYSA-N CCCCCCCCCC[Si](C)(C)C Chemical compound CCCCCCCCCC[Si](C)(C)C WTZBVIIGQDJARG-UHFFFAOYSA-N 0.000 description 3
- ZXRMQGNWCVLSLZ-UHFFFAOYSA-N CCN(CC)CCC[Si](C)(C)C Chemical compound CCN(CC)CCC[Si](C)(C)C ZXRMQGNWCVLSLZ-UHFFFAOYSA-N 0.000 description 3
- XLWWCZDAVJAHDT-UHFFFAOYSA-N C[Si](C)(C)CCCOP(C)(=O)O Chemical compound C[Si](C)(C)CCCOP(C)(=O)O XLWWCZDAVJAHDT-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical group OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 3
- 125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 150000007942 carboxylates Chemical group 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 230000009920 chelation Effects 0.000 description 3
- YSSSPARMOAYJTE-UHFFFAOYSA-N dibenzo-18-crown-6 Chemical compound O1CCOCCOC2=CC=CC=C2OCCOCCOC2=CC=CC=C21 YSSSPARMOAYJTE-UHFFFAOYSA-N 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229960000575 trastuzumab Drugs 0.000 description 3
- HLWCOIUDOLYBGD-UHFFFAOYSA-N trichloro(decyl)silane Chemical compound CCCCCCCCCC[Si](Cl)(Cl)Cl HLWCOIUDOLYBGD-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 0 **O[Si](CC[Si](CCCN(CC)CC)(O*C)O*C)(O*C)O*C Chemical compound **O[Si](CC[Si](CCCN(CC)CC)(O*C)O*C)(O*C)O*C 0.000 description 2
- HTTJQQJDZPVTGE-UHFFFAOYSA-N 1-[decyl(dimethyl)azaniumyl]propane-1-sulfonate Chemical compound CCCCCCCCCC[N+](C)(C)C(CC)S([O-])(=O)=O HTTJQQJDZPVTGE-UHFFFAOYSA-N 0.000 description 2
- WKALLSVICJPZTM-UHFFFAOYSA-N 3-[decyl(dimethyl)azaniumyl]propane-1-sulfonate Chemical compound CCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O WKALLSVICJPZTM-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- XZKPGANJFMYQDE-UHFFFAOYSA-N C[Si](C)(C)CCCNC(=O)C(O)C(O)C(O)C(O)CO Chemical compound C[Si](C)(C)CCCNC(=O)C(O)C(O)C(O)C(O)CO XZKPGANJFMYQDE-UHFFFAOYSA-N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 108010001441 Phosphopeptides Proteins 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000005341 cation exchange Methods 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229960003964 deoxycholic acid Drugs 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229950008882 polysorbate Drugs 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 229940117986 sulfobetaine Drugs 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- HCJJCGDDYHYMDL-CHWFTXMASA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxy-n-(3-trimethoxysilylpropyl)hexanamide Chemical compound CO[Si](OC)(OC)CCCNC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO HCJJCGDDYHYMDL-CHWFTXMASA-N 0.000 description 1
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 description 1
- 125000006732 (C1-C15) alkyl group Chemical group 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- VEBPJGSQTAEARZ-RHYVBRDVSA-N CC(C)(C)[Si](C)(C)C.CCCCCCCCCC[Si](C)(C)C.CCC[Si](C)(C)C.CCC[Si](C)(CC(C)C)CC(C)C.CC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)NCCC[Si](C)(C)C.C[Si](C)(C)C.C[Si](C)(C)CCCCC1=CC=CC=C1.C[Si](C)(C)CCCCCCC1=CC=CC=C1.C[Si](C)(C)CCCCCCC1=CC=CC=C1 Chemical compound CC(C)(C)[Si](C)(C)C.CCCCCCCCCC[Si](C)(C)C.CCC[Si](C)(C)C.CCC[Si](C)(CC(C)C)CC(C)C.CC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)NCCC[Si](C)(C)C.C[Si](C)(C)C.C[Si](C)(C)CCCCC1=CC=CC=C1.C[Si](C)(C)CCCCCCC1=CC=CC=C1.C[Si](C)(C)CCCCCCC1=CC=CC=C1 VEBPJGSQTAEARZ-RHYVBRDVSA-N 0.000 description 1
- ZEGHHDDGWOWCDI-UHFFFAOYSA-N CC(CO)COCCC[Si](C)(C)C.CCCCCCCCCCCCCCCCCC[Si](C)(C)C.COC(=O)CC[Si](C)(C)C.C[N+](C)(CCCC(=O)[O-])CCC[Si](C)(C)C.C[N+](C)(CCC[Si](C)(C)C)CCCS(=O)(=O)[O-].C[Si](C)(C)C1=CC=CC=C1.C[Si](C)(C)CCCOCC1CC1.C[Si](C)(C1=CC=CC=C1)C1=CC=CC=C1 Chemical compound CC(CO)COCCC[Si](C)(C)C.CCCCCCCCCCCCCCCCCC[Si](C)(C)C.COC(=O)CC[Si](C)(C)C.C[N+](C)(CCCC(=O)[O-])CCC[Si](C)(C)C.C[N+](C)(CCC[Si](C)(C)C)CCCS(=O)(=O)[O-].C[Si](C)(C)C1=CC=CC=C1.C[Si](C)(C)CCCOCC1CC1.C[Si](C)(C1=CC=CC=C1)C1=CC=CC=C1 ZEGHHDDGWOWCDI-UHFFFAOYSA-N 0.000 description 1
- FFXWFHFFAVVNLP-UHFFFAOYSA-N CCCC[Si](C)(C(C)C)C(C)C.C[Si](C)(C)CCC(=O)O.C[Si](C)(C)CCC1=CC=NC=C1.C[Si](C)(C)CCCN.C[Si](C)(C)CCCN(CCO)CCC[Si](C)(C)C.C[Si](C)(C)CCCS(=O)(=O)O.C[Si](C)(C)CN(C[Si](C)(C)C)C[Si](C)(C)C Chemical compound CCCC[Si](C)(C(C)C)C(C)C.C[Si](C)(C)CCC(=O)O.C[Si](C)(C)CCC1=CC=NC=C1.C[Si](C)(C)CCCN.C[Si](C)(C)CCCN(CCO)CCC[Si](C)(C)C.C[Si](C)(C)CCCS(=O)(=O)O.C[Si](C)(C)CN(C[Si](C)(C)C)C[Si](C)(C)C FFXWFHFFAVVNLP-UHFFFAOYSA-N 0.000 description 1
- JFOPBFWIPDFSSB-UHFFFAOYSA-M CCN(CC)CCC[Si](C)(C)C.CN(CCC[Si](C)(C)C)CCC[Si](C)(C)C.C[Si](C)(C)CCCCC1CCCCC1.C[Si](C)(C)CCCCCCN.C[Si](C)(C)CCCCCCN.C[Si](C)(C)CCCOP(C)(=O)[O-].C[Si](C)(C)CN1CCCCC1.C[Si](C)(C)CNC1CCCCC1.[Na+] Chemical compound CCN(CC)CCC[Si](C)(C)C.CN(CCC[Si](C)(C)C)CCC[Si](C)(C)C.C[Si](C)(C)CCCCC1CCCCC1.C[Si](C)(C)CCCCCCN.C[Si](C)(C)CCCCCCN.C[Si](C)(C)CCCOP(C)(=O)[O-].C[Si](C)(C)CN1CCCCC1.C[Si](C)(C)CNC1CCCCC1.[Na+] JFOPBFWIPDFSSB-UHFFFAOYSA-M 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- VZYFZWFIQGVAKS-UHFFFAOYSA-N OCCN(CCC[SiH3])CCC[SiH3] Chemical compound OCCN(CCC[SiH3])CCC[SiH3] VZYFZWFIQGVAKS-UHFFFAOYSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- QOMOGBQIMSWRFH-UHFFFAOYSA-N [SiH3]CCCN(C)CCC[SiH3] Chemical compound [SiH3]CCCN(C)CCC[SiH3] QOMOGBQIMSWRFH-UHFFFAOYSA-N 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910001423 beryllium ion Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000010574 gas phase reaction Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- UWNADWZGEHDQAB-UHFFFAOYSA-N i-Pr2C2H4i-Pr2 Natural products CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- VQECZZRUEDMVCU-UHFFFAOYSA-N methoxy-[4-[methoxy(dimethyl)silyl]phenyl]-dimethylsilane Chemical compound CO[Si](C)(C)C1=CC=C([Si](C)(C)OC)C=C1 VQECZZRUEDMVCU-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WTXITWGJFPAEIU-UHFFFAOYSA-N n-methyl-3-trimethoxysilyl-n-(3-trimethoxysilylpropyl)propan-1-amine Chemical compound CO[Si](OC)(OC)CCCN(C)CCC[Si](OC)(OC)OC WTXITWGJFPAEIU-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- OXUCOTSGWGNWGC-UHFFFAOYSA-N octane Chemical compound CCCCCCC[CH2-] OXUCOTSGWGNWGC-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 150000004819 silanols Chemical class 0.000 description 1
- 238000010530 solution phase reaction Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- MMZPUXVBQAQQDQ-UHFFFAOYSA-N triethoxy(2-pyridin-4-ylethyl)silane Chemical compound CCO[Si](OCC)(OCC)CCC1=CC=NC=C1 MMZPUXVBQAQQDQ-UHFFFAOYSA-N 0.000 description 1
- MAFQBSQRZKWGGE-UHFFFAOYSA-N trimethoxy-[2-[4-(2-trimethoxysilylethyl)phenyl]ethyl]silane Chemical compound CO[Si](OC)(OC)CCC1=CC=C(CC[Si](OC)(OC)OC)C=C1 MAFQBSQRZKWGGE-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000005019 vapor deposition process Methods 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/366—Ion-pair, e.g. ion-pair reversed phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/22—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the construction of the column
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/32—Bonded phase chromatography
- B01D15/325—Reversed phase
- B01D15/327—Reversed phase with hydrophobic interaction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3847—Multimodal interactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
- B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
- B01D15/1878—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series for multi-dimensional chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
- B01D15/206—Packing or coating
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/50—Conditioning of the sorbent material or stationary liquid
- G01N30/56—Packing methods or coating methods
- G01N2030/567—Packing methods or coating methods coating
Definitions
- the present disclosure relates to methods of separating an analyte(s) from a sample. More particularly, the present disclosure relates to active coatings that are vapor deposited onto at least a portion of a flow path (wetted surfaces) of a chromatographic system to interact with at least one analyte in the sample through a repulsive force, a secondary interaction, or a retention mechanism distinct from the interaction with the stationary phase material.
- Analytes that interact with metal have often proven to be very challenging to separate.
- the desire to have high pressure capable chromatographic systems with minimal dispersion has required that flow paths decrease in diameter and be able to withstand increasingly high pressures at increasingly fast flow rates.
- the material of choice for chromatographic flow paths is often metallic in nature. This is despite the fact that characteristics of certain analytes, for example, biomolecules, proteins, glycans, peptides, oligonucleotides, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and neurotransmitters, are known to have unfavorable interactions, so called chromatographic secondary interactions, with metallic surfaces.
- analytes having phosphate groups are excellent polydentate ligands capable of high affinity metal chelation. This interaction causes phosphorylated species to bind to the flow path metals thus reducing the detected amounts of such species, a particularly troublesome effect given that phosphorylated species are frequently the most important analytes of an assay.
- carboxylate groups also have the ability to chelate to metals, albeit with lower affinities than phosphate groups.
- carboxylate functional groups are ubiquitous in, for example, biomolecules, giving the opportunity for cumulative polydentate-based adsorptive losses. These complications can exist not only on peptides and proteins, but also glycans.
- N-glycan species can at times contain one or more phosphate groups as well as one or more carboxylate containing sialic acid residues.
- smaller biomolecules such as nucleotides and saccharides, like sugar phosphates, can exhibit similar behavior to the previously mentioned N-glycan molecules.
- chromatographic secondary interactions can be especially problematic with biomolecules, particularly larger structures, because they have a capacity (via their size and structural order) to form microenvironments that can adversely interact with separation components and flow path surfaces.
- a biomolecule or analyte having larger structures can present structural regions with chemical properties that amplify a secondary interaction to the material of a flow path. This, combined with the cumulative metal chelation effects curtails the overall effective separation of biomolecules, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and meurotransmitters.
- PEEK polyether ether ketone
- PEEK tubing like most polymeric materials, is formed by means of an extrusion process. With polymeric resin, this manufacturing process can lead to highly variable internal diameters. Accordingly, PEEK column hardware yields unfavorable differences in the retention times as can be observed from switching between one column and the next. Often, this variation can be a factor of three higher than a metal constructed column.
- the techniques for fabricating polymer based frits are not yet sufficiently optimized to afford suitably rugged components for commercial HPLC columns. For example, commercially available PEEK frits tend to exhibit unacceptably low permeability.
- an ‘active’ coating can introduce a Coulombic repulsive effect with an analyte to shield them from interacting with the substrate material (e.g., metal, plastic, etc.) of the flow path in a way that negatively affects the chromatographic separation.
- an ‘active’ coating can be produced that adds an enhancing selectivity to a separation by way of a subtle secondary interaction.
- an ‘active’ coating can be prepared that affords an entirely orthogonal retention mechanism, which facilitates the adsorption, partitioning, and desorption of analytes in a process distinct from that achieved with the stationary phase of a column.
- the present disclosure provides a number of advantages over current systems and methodology.
- the technology of the present disclosure not only reduces unwanted interactions between analytes and metallic or polymeric surfaces, but modifies the surfaces of a chromatographic flow path in such a way as to positively affect the separation, for example, by enhancing selectivity.
- the chromatographic separation can be effected and enhanced not just by the chromatographic stationary phase material but also by other chromatographic surfaces that interact with the analytes.
- the technology relates to a method of separating analytes in a sample.
- the method includes introducing a sample comprising the analytes into a chromatographic system.
- the chromatographic system includes a flow path disposed in an interior of the chromatographic system where at least a portion of the flow path having an active coating, and a chromatographic column having a stationary phase material in an interior of the chromatographic column that facilitates separation of the analytes in the sample through interaction with at least one analyte in the sample.
- the active coating is selected to interact with at least one analyte in the sample through (1) a repulsive force, (2) a secondary interaction, or (3) a retention mechanism distinct from the interaction with the stationary phase material.
- the method can include one or more of the embodiments described herein.
- the analyte and the active coating are negatively charged.
- the analyte and active coating can be positively charged.
- the active coating is applied to the flow path by vapor deposition.
- the active coating can be applied to a frit.
- the frit can be positioned at an outlet of the chromatographic column. In some embodiments, the frit is positioned at an inlet of the chromatographic column.
- the chromatographic column can have two frits, one positioned at the outlet of the chromatographic column and one positioned at the inlet of the chromatographic column.
- the secondary interaction is ion exchange partitioning.
- the technology in another aspect, relates to a chromatographic device for separating analytes in a sample.
- the device includes a sample injector having a sample injection needle for injecting the sample into the mobile phase, a sample reservoir container in fluid communication with the sample injector, a chromatography column downstream of the sample injector, the chromatography column having fluid connectors, and fluid conduits connecting the sample injector and the chromatography column.
- the fluid connectors are connect post-column detector(s) and devices.
- Interior surfaces of the fluid conduits, sample injector, sample reservoir container, and chromatography column form a fluidic flow path having wetted surfaces. At least a portion of the wetted surfaces of the fluidic flow path are coated with an alkylsilyl coating having the Formula I:
- Each X is independently selected from (C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, OR A , R B , R C , R D and halo.
- R A represents a point of attachment to the interior surfaces of the fluidic system and at least one X is OR A .
- R B is absent or represents a hydrophobicity modifier.
- R C represents a charge modifier and at least one X is R C .
- R D is absent, a chelator, or a crown ether.
- Y is a bridging moiety selected from (C 1 -C 20 )alkyl, —O[(CH 2 ) 2 O] 1-20 —, —(C 1 -C 10 )[NH(CO)NH(C 1 -C 10 )] 1-20 -, or —(C 1 -C 10 )[alkylphenyl(C 1 -C 10 )alkyl] 1-20 -.
- the device can include one or more of the embodiments described herein.
- the charge modifier has the same charge as at least one analyte in the sample.
- the charge modifier (R C ) can be attached to Formula I by a silyl ether moiety and has a composition selected from the group consisting of n-cyclohexylaminomethyl silyl , n-(2-aminoethyl)-3-aminopropyl silyl , n-cyclohexyl-3-aminopropyl silyl, n-(2-aminoethyl)-3-aminopropylmethyl silyl, n-cyclohexylaminomethyl silyl, bis (silylpropyl)-n-methylamine, 3-aminopropyl diisopropyl silyl, (3-aminopropyl) silyl, n,n-diethyl-3-aminopropyl silyl, propanesulfonic acid silyl, N-(hydroxyethyl)-N,
- the charge modifier (R C ) is
- Z is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- the charge modifier (R C ) is
- Z is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- the charge modifier (R C ) is a quaternary amine.
- the alkylsilyl coating of Formula I can be at least 100 ⁇ thick.
- the charge modifier (R C ) has a surface coverage between about 0.01 ⁇ mol/m 2 and about 10 ⁇ mol/m 2 .
- the charge modifier (R C ) can have a surface coverage between about 0.02 ⁇ mol/m 2 and about 1 ⁇ mol/m 2 .
- the hydrophobicity modifier (R B ) is present.
- the hydrophobicity modifier (R B ) can have a net neutral charge.
- the hydrophobicity modifier (R B ) can be attached to Formula I by a silyl ether moiety and can have a composition selected from the group consisting of n-decyl silyl, trimethyl silyl, n-propyl silyl, t-butyl dimethyl silyl, 4-phenylbutyl silyl, n-octadecyl diisobutyl silyl, 6-phenylhexyl silyl, n-octadecyl silyl, n-methyl-O-methyl carbamate silyl, phenyl silyl, diphenyl methyl silyl, sulfobetaine silyl, carboxybetaine silyl, glycidoxy propyl silyl, hydrolyzed glycidoxypropyl silyl
- the hydrophobicity modifier (R B ) is
- Z is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- the hydrophobicity modifier (R B ) is
- Z is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- the alkylsilyl coating of Formula I is
- At least one X is the charge modifier (R C ), wherein R C is
- R B is the hydrophobicity modifier
- Z is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- the alkylsilyl coating of Formula I is
- At least one X is the charge modifier (R C ), wherein R C is
- R B is the hydrophobicity modifier
- Z is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- the alkylsilyl coating of Formula I is
- At least one X is the charge modifier (R C ), wherein R C is
- R B is the hydrophobicity modifier
- Z is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- the hydrophobicity modifier (R B ) has a surface coverage between about 0.01 ⁇ mol/m 2 and about 10 ⁇ mol/m 2 .
- the hydrophobicity modifier (R B ) can have a surface coverage between about 0.03 ⁇ mol/m 2 and about 0.9 ⁇ mol/m 2 .
- the hydrophobicity modifier has a surface coverage between about 0.5 ⁇ mol/m 2 and about 3 ⁇ mol/m 2 .
- the chromatography column can include a frit having a wetted surface coated with the alkylsilyl coating of Formula I.
- the frit can be positioned at an outlet of the chromatography column. In some embodiments, the frit is positioned at an inlet of the chromatography column.
- the chromatographic column can have two fits, one positioned at the outlet of the chromatographic column and one positioned at the inlet of the chromatographic column
- the hydrophobicity modifier (R B ) is present.
- the device can also include a detector downstream of the chromatography column, wherein the fluidic flow path further comprises the detector.
- the detector can be a mass spectrometer and the fluidic flow path include wetted surfaces of an electrospray needle.
- R D is present.
- R D can be the chelator and the chelator can be ethylenediaminetetraacetic acid.
- R D is the chelator and the chelator is etidronic acid.
- R D can be the crown ether and the crown ether can be selected from the group consisting of 18-crown-6, 12-crown-4, 15-crown-5, dibenzo-18-crown-6, and diaza-18-crown-6.
- the technology features a method of separating a sample comprising an anionic compound.
- the method includes introducing the sample comprising the anionic compound to a fluidic system including a flow path disposed in an interior of the fluidic system, wherein at least a portion of the flow path comprising an alkylsilyl coating having the Formula I:
- Each X is independently selected from (C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, OR A , R B , R C , R D and halo.
- R A represents a point of attachment to the interior surfaces of the fluidic system and at least one X is OR A .
- R B is absent or represents a hydrophobicity modifier.
- R C represents a negatively-charged modifier and at least one X is R C .
- R D is absent, a chelator, or a crown ether.
- Y is a bridging moiety selected from (C 1 -C 20 )alkyl, —O[(CH 2 ) 2 O] 1-20 —, —(C 1 -C 10 )[NH(CO)NH(C 1 -C 10 )] 1-20 -, or —(C 1 -C 10 )[alkylphenyl(C 1 -C 10 )alkyl] 1-20 -.
- the method also includes eluting the sample through the fluidic system, wherein the anionic compound is repelled by the negatively-charged modifier (R C ), and isolating the anionic compound.
- the method can include one or more of the embodiments described herein.
- the anionic compound is a nucleic acid.
- the anionic compound can be an oligonucleotide.
- the alkylsilyl coating of Formula I is
- the technology features a method of separating a sample comprising peptides.
- the method includes introducing the sample comprising peptides into a chromatography column having a hydrophobic stationary phase disposed within the chromatography column and a frit at an outlet of the chromatography column, wherein the frit is coated with an alkylsilyl coating having the Formula I:
- Each X is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, OR A , R B , R C , R D and halo.
- R A represents a point of attachment to the interior surfaces of the fluidic system and at least one X is OR A .
- R B represents a hydrophobicity modifier and at least one X is R B .
- R C represents a charge modifier and at least one X is R C .
- Y is a bridging moiety selected from (C 1 -C 20 )alkyl, —O[(CH 2 ) 2 O] 1-20 —, —(C 1 -C 10 )[NH(CO)NH(C 1 -C 10 )] 1-20 -, or —(C 1 -C 10 )[alkylphenyl(C 1 -C 10 )alkyl] 1-20 -.
- the charge modifier has a surface coverage of between about 0.03 ⁇ mol/m 2 to about 0.9 ⁇ mol/m 2 and the hydrophobicity modifier has a surface coverage of between about 0.5 ⁇ mol/m 2 to about 3 ⁇ mol/m 2 .
- the method also includes eluting the sample through the chromatography column and isolating the peptides.
- the method can include one or more of the embodiments described herein.
- the charge modifier is N,N-(diethylaminopropyl)silyl.
- the hydrophobicity modifier can be n-decyl silyl.
- the peptides include Asp and iso ASP isomeric peptide pair.
- the method can also include partitioning the Asp and iso ASP isomeric peptide pair on the coated frit.
- the hydrophobic stationary phase comprises a bridged ethylene hybrid C18 stationary phase.
- the sample can include trypsinized immunoglobulin.
- the trypsinized immunoglobulin is trastuzumab.
- the technology includes a method of separating a sample comprising proteins.
- the method includes introducing the sample comprising proteins into a chromatography column having a hydrophobic stationary phase disposed within the chromatography column and a frit at an inlet of the chromatography column, wherein the frit is coated with an alkylsilyl coating having the Formula I:
- Each X is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, OR A , R B , R C , R D and halo.
- R A represents a point of attachment to the interior surfaces of the fluidic system and at least one X is OR A .
- R C represents a charge modifier and at least one X is R C .
- Y is a bridging moiety selected from (C 1 -C 20 )alkyl, —O[(CH 2 ) 2 O] 1-20 —, —(C 1 -C 10 )[NH(CO)NH(C 1 -C 10 )] 1-20 -, or —(C 1 -C 10 )[alkylphenyl(C 1 -C 10 )alkyl] 1-20 -.
- the charge modifier has a surface coverage of between about 0.1 ⁇ mol/m 2 to about 3 ⁇ mol/m 2 .
- the method also includes eluting the sample through the chromatography column, and isolating the proteins.
- the method can include one or more of the embodiments described herein.
- the hydrophobic stationary phase includes a bridged ethylene hybrid C4 stationary phase.
- the charge modifier can be silyl propyl methyl phosphonate.
- the method can also include flowing a mobile phase having an ionic strength through the chromatography column such that the proteins are retained on the frit, increasing the ionic strength of the mobile phase to displace a portion of the proteins from the frit, and eluting the displaced proteins through the chromatography column.
- FIG. 1 is a schematic of a chromatographic flow system including a chromatography column and various other components, in accordance with an illustrative embodiment of the technology.
- a fluid is carried through the chromatographic flow system with a fluidic flow path extending from a fluid manager to a detector.
- FIG. 2 is a chart showing exemplary embodiments of coatings, in accordance with an illustrative embodiment of the technology.
- Flow path components for liquid chromatography can be modified with an organosilica (alkylsilyl) functionality to purposefully exhibit chemical properties of effect to a chromatographic separation.
- An ‘active’ coating such as this can introduce a Coulombic repulsive effect with an analyte to shield the analyte from interacting with the substrate material of the flow path.
- an ‘active’ coating can be produced that adds an enhancing selectivity to a separation by way of a secondary interaction.
- an ‘active’ coating can be prepared that affords an entirely orthogonal retention mechanism, which facilitates the adsorption, partitioning, and desorption of analytes in a process, distinct from that achieved with the stationary phase of a column.
- Organosilica is a versatile composition to use in the coating of both metallic and polymeric flow path components, which can range from an injector needle and pre-column heater to post-column tubing, column housings, frits, detector flow cells, and electrospray needles.
- the organosilica (alkyksilyl) coating can be applied via either gas phase or solution phase reactions and with a host of different silanizing reagents.
- an alkylsilyl coating can be applied via vapor deposition, which can then be deliberately doped with a charged surface modifier.
- a number of aspects of the technology are directed to (1) devices having an alkylsilyl ‘active’ coating; (2) methods of isolating an analyte in a sample, in particular a metal-interacting analyte; and (3) kits comprising various chromatographic components coated with an alkylsilyl ‘active’ coating and instructions for use.
- a coating is used to modify a flow path to address flow path interactions with an analyte and to interact with the analyte so that the chromatographic separation is improved, for example, increasing selectivity of the analyte of interest. That is, the active coating minimizes surface reactions with the metal interacting analyte while at the same time interacting with the analyte to improve separations.
- the reduction/elimination of the interactions between the analyte and the metal is advantageous because it allows for accurate quantification and analysis of a sample containing a metal-interacting analyte, for example, biomolecules, proteins, glycans, peptides, oligonucleotides, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and neurotransmitters.
- the biomolecule can be selected from a peptide or peptide fragment, an oligopeptide, a protein, a glycan, a nucleic acid or nucleic acid fragment, a growth factor, a carbohydrate, a fatty acid, and a lipid.
- the biomolecule is a protein, a peptide, or a glycan.
- the biomolecule can be a phosphoglycan or a phosphopeptide.
- the ‘active’ coating has further advantages in that the coating interacts with the analyte to improve separations.
- the active coating can improve separations by, for example, actively repelling the analyte from the metallic surfaces, introducing a secondary interaction between the coating and the analyte that enhances selectivity, and/or provides an orthogonal retention mechanism that is different from the retention mechanism of the stationary phase material.
- vapor deposited alkylsilyl coatings on wetted surfaces of fluidic systems modify the fluidic flow path to introduce an interaction between the alkylsilyl coating and the analyte(s).
- they are ‘active’ coatings (meaning that the analyte(s) of the sample interact with the alkylsilyl coating).
- FIG. 1 is a representative schematic of a chromatographic flow system/device 100 that can be used to separate analytes in a sample.
- Chromatographic flow system 100 includes several components including a fluid manager system 105 (e.g., controls mobile phase flow through the system), tubing 110 (which could also be replaced or used together with microfabricated fluid conduits), fluid connectors 115 (e.g., fluidic caps), frits 120 , a chromatography column 125 , a sample injector 135 including a sample injection needle (not shown) to insert or inject the sample into the mobile phase, a vial, sinker, or sample reservoir 130 for holding the sample prior to injection, a detector 150 located downstream of the chromatography column 125 , and a pressure regulator 140 for controlling pressure of the flow.
- a fluid manager system 105 e.g., controls mobile phase flow through the system
- tubing 110 which could also be replaced or used together with microfabricated fluid conduits
- fluid connectors 115 e.g., fluidic caps
- the sample reservoir 130 is in fluid communication with the sample injection needle. Interior surfaces of the components of the chromatographic system/device form a fluidic flow path that has wetted surfaces.
- the fluidic flow path can have a length to diameter ratio of at least 20, at least 25, at least 30, at least 35 or at least 40.
- the fluidic flow path can include the detector 150 .
- the detector 150 can be a mass spectrometer.
- the fluidic flow path can include wetted surfaces of an electrospray needle (not shown).
- At least a portion of the wetted surfaces can be coated with an alkyl silyl coating, described in detail herein, selected to interact with the analyte(s) in the sample to improve the separation of the analyte(s) in the sample.
- the coating can be applied by vapor deposition.
- the alkylsilyl coating can be provided throughout the system from the tubing or fluid conduits 110 extending from the fluid manager system 105 all the way through to the detector 150 .
- the coatings can also be applied to portions of the fluidic fluid path. That is, one may choose to coat one or more components or portions of a component and not the entire fluidic path. For example, the internal portions of the column 125 and its frits 120 and end caps 115 can be coated whereas the remainder of the flow path can be left unmodified. Further, removable/replaceable components can be coated. For example, the vial or sinker 130 containing the sample reservoir can be coated as well as frits 120 .
- one or both frits 120 have a wetted surface that is coated with one of the alkylsilyl coatings described in detail herein (for example the coatings shown in FIG. 2 ).
- a frit 120 can be positioned at the inlet or outlet of the column 125 .
- the column 125 has a frit 120 positioned at both the inlet and outlet of the column 125 .
- the chromatographic column 125 can be designed such that the inlet and/or outlet frit 120 is replaceable. In this way, if the frit 120 is coated with an alkyl silyl coating described herein, the frit 120 can be easily replaced with a frit having a different alkyl silyl coating to achieve a different effect.
- the flow path of the fluidic systems described herein is defined at least in part by an interior surface of tubing. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of microfabricated fluid conduits. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of a column. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by passageways through a frit. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of a sample injection needle. In another aspect, the flow path of the fluidic systems described herein extends from the interior surface of a sample injection needle throughout the interior surface of a column. In another aspect, the flow path extends from a sample reservoir container (e.g. sinker) disposed upstream of and in fluidic communication with the interior surface of a sample injection needle throughout the fluidic system to a connector/port to a detector.
- a sample reservoir container e.
- only the wetted surfaces of the chromatographic column and the components located upstream of the chromatographic column are coated with the alkylsilyl coatings described herein while wetted surfaces located downstream of the column are not coated.
- the coating can be applied to the wetted surfaces via vapor deposition.
- At least a portion of the wetted surfaces of the fluidic flow path are coated with an alkylsilyl coating having Formula I:
- Each X is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, OR A , R B , R C , R D and halo.
- X is independently selected from OR A , R B , R C , and R D .
- C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, and halo are reactive/hydrolysable groups.
- these groups provide residual reactive groups where amino>halo>alkoxy as it relates to silane reactivity.
- the specific coating that is used depends on the type of chromatographic separation being performed. The goal is to create chemically stable (good longevity) coatings on various materials present in a chromatographic flow path. However, hydrophilic coatings have no interactions in reversed phase liquid chromatography, while hydrophilic coatings can exhibit some retention in hydrophilic interaction chromatography. While one coating may suffice for multiple different chemical separations, different coatings can also be used for different modes of liquid chromatography.
- R A represents a point of attachment to the interior surfaces of the fluidic system and at least one X is OR A .
- R B is absent or represents a hydrophobicity modifier.
- R C represents a charge modifier and at least one X is R C .
- R D is absent, a chelator, or a crown ether.
- Y is a bridging moiety selected from (C 1 -C 20 )alkyl, —O[(CH 2 ) 2 O] 1-20 —, —(C 1 -C 10 )[NH(CO)NH(C 1 -C 10 )] 1-20 -, or —(C 1 -C 10 )[alkylphenyl(C 1 -C 10 )alkyl] 1-20 -.
- Y can be dictated by both chemical and physical consideration. While not being limited by theory, short alkyl chains can produce more rigid, mechanically stronger substrates. However, alkyl bridging (Y) groups can yield materials with significant hydrophobicity. Accordingly, heteroatom containing Y groups can be employed. Furthermore, phenyl/aromatic groups can be used to introduce pi electrons that alter the electrostatic density and adsorption properties of the substrate.
- the alkylsilyl coating of Formula I has at least one X that is OR A , a point of attachment to the interior surfaces of the fluidic system and at least one X that is R C , which represents a charge modifier.
- the hydrophobicity modifier R B and the chelator or crown ether R D can be absent.
- the alkylsilyl coating of Formula I has a charge modifier.
- the alkylsilyl coating of Formula I has a charge modifier and a hydrophobicity modifier.
- the alkylsilyl coating of Formula I has a charge modifier and a chelator or crown ether.
- the alkylsilyl coating of Formula I has a charge modifier, a hydrophobicity modifier and a chelator or crown ether.
- the alkylsilyl coating of Formula I has at least one X that is OR A , a point of attachment to the interior surfaces of the fluidic system and at least one X that is R C , which represents a chelator or crown ether.
- the alkylsilyl coating of Formula I has a chelator or crown ether and a hydrophobicity modifier.
- a hyphen (“-”) indicates the point of attachment.
- Y is —[(C 1 -C 10 )alkylphenyl(C 1 -C 10 )alkyl] 1-20 -, that means that Y is connected to one SiX 3 via the (C 1 -C 10 )alkyl and connected to the other SiX 3 via the other (C 1 -C 10 )alkyl. This applies to the remaining variables.
- Y in Formula I is (C 1 -C 15 )alkyl, (C 1 -C 12 )alkyl, or (C 1 -C 10 )alkyl.
- Y in Formula I is methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, iso-butyl, t-butyl, pentyl, hexyl, heptyl, nonyl, or decanyl.
- Y in Formula I is ethyl or decanyl.
- X can be another Y bridging moiety.
- the alkylsilyl coating can have more than two Si atoms bridged by two separated Y bridging moieties.
- the Y bridging moieties can be the same Y moiety or different Y moieties.
- Multiple bridging moieties can result in the alkylsily coating being in a straight chain or branched.
- an alkylsilyl coating having multiple Y bridging moieties can be hyper-crosslinked with extensive bridging.
- the first bridging alkylsilyl composition can be highly crosslinked with some surface heterogeneity and mix of bridging moieties and silanols. That surface can then be modified with one or more of the modifiers described herein (e.g., charge modifiers, hydrophobicity modifiers, chelators and/or crown ethers, or surfactants).
- the modifiers described herein e.g., charge modifiers, hydrophobicity modifiers, chelators and/or crown ethers, or surfactants.
- the active alkylsilyl coating is comprised at least in part by Formula I as described herein.
- the alkylsilyl coating of Formula I is at least a portion of the coating.
- the coating could have other Y bridging moieties with multiple modifiers as described herein.
- the coating can be tailored to provide different microporosities and densities. Temperatures, vapor concentrations, and rates of deposition or hydrolysis can be adjusted to alter the porosity, density and thickness of the coating. Denser coatings are advantageous for minimizing ion and liquid transfer. Denser coatings are preferred to mitigate corrosion and to limit long distance interactions between analytes and flow path substrates.
- a bridging silane reagent is first applied to wetted surfaces of the fluidic flow path via vapor deposition to achieve a high build, e.g., greater than about 100 ⁇ thick base layer, resulting in Formula I once deposited onto the wetted surfaces of the fluidic flow path.
- the thickness can be between about 100 ⁇ to about 1600 ⁇ .
- the thickness of the coating can be about 100 ⁇ , 200 ⁇ , 300 ⁇ , 400 ⁇ , 500 ⁇ , 600 ⁇ , 700 ⁇ , 800 ⁇ , 900 ⁇ , 1000 ⁇ , 1100 ⁇ , 1200 ⁇ , 1300 ⁇ , 1400 ⁇ , 1500 ⁇ , or 1600 ⁇ .
- the reagent can be, for example, bis(trichlorosilyl)ethane, bis(3-trimethoxysilylpropyl)-N-methylamine, 1,4-bis(methoxydimethylsilyl)benzene, bis(trimethoxysilylethyl)benzene, 1,8-bis(triethyoxysilyl)octane, or 1,4-bis(triethyoxysilyl)benzene.
- a single modifier is used, for example, a single charge modifier.
- multiple modifiers are used, for example, multiple charge modifiers or combinations or charge modifiers and hydrophobicity modifiers.
- a charge modifying salinizing reagent can be applied onto a suitable base layer.
- These charge bearing surface modifiers are comprised of strong acids/bases or weak acids/bases with a dissociation constant selected in a desirable range of pKa and can include but are not limited to trimethoxy silyl propyl methyl phosphonate and N,N-(diethylaminopropyl) trimethoxysilane.
- Strong acids can be desirable in some applications and be selected to have a pKa from about ⁇ 2 to about 2, while other applications are more desirable with week acids have a pKa from about 2 to about 7.
- Surface modifiers with fixed charges can also be employed. These surface modifiers can be incorporated in situ during a vapor deposition process or through secondary, liquid phase reactions that are broadly employed by those skilled in the art.
- liquid phase reactions can include multiple steps so as to build the desired charge modifying moiety. For example for separation of nucleic acids or phosphopeptides that are negatively charged, the surface charge can be negative. In such case, the analytes are repelled from the surface and have no losses due to non-specific adsorption.
- the charge modifier (R C ) can have the same charge as at least one analyte in the sample.
- the charge modifier introduces a Coulombic repulsive effect with the sample(s) having the same charge (i.e., like charges repel). This repulsive effect shields the analyte(s) from interacting with the substrate material of the flow path.
- the selection of an appropriate charge modifier can also depend on practical limitations, for example whether a suitable silane reagent can be sourced, or if it is to be synthesized, it is can be vaporized or made to be soluble in a suitable solvent system to carry out a reaction.
- the stability of the resulting coating should be considered. For example, a strong base that is also a nucleophile can be problematic because it can self catalyze its hydrolytic degradation.
- charge modifiers can also facilitate multidimensional chromatography by strongly retaining a class of analytes by a retention mechanism that is orthogonal to that of an implemented liquid chromatography column.
- analytes adsorb to a flow path component having an alkylsilyl coating with a charge modifier (e.g., a frit at the entrance of a chromatography column), are eluted to a downstream chromatography column in a gradient or set of discrete mobile phase changes and secondary gradients across the packed bed of the chromatography column are thereafter performed.
- a charge modifier e.g., a frit at the entrance of a chromatography column
- the charge modifier can be, for example, any one or more of the following charge modifiers: a quaternary amine,
- Z is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I. Therefore, the charge modifier is covalently bound to the alkylsilyl coating of Formula I by a silyl ether moiety.
- a corresponding charge modifying reagent can be used to obtain the charge modifier of the final coating product, for example, the charge modifying reagent can be trimethoxy silyl propyl methyl phosphonate or N,N-(diethylaminopropyl) trimethoxysilane, or 2-(4-pyridylethyl)triethoxysilane.
- a single charge modifier is applied to the vapor deposited alkylsilyl (Formula I).
- multiple charge modifiers are applied to the vapor deposited alkylsilyl (Formula I).
- the multiple charge modifiers can be the same charge modifier applied at multiple X positions of Formula I.
- the multiple charge modifiers can be different charge modifiers applied at different X positions of Formula I.
- a vapor deposition alylsilyl coating can be deliberately doped with a charged surface modifier (R C ), for example, the charged surface modifiers of U.S. Pat. No. 10,159,911 issued Dec. 25, 2018 and entitled “High Purity Chromatographic Materials Comprising an Ionizable Modifier,” the entire contents of which is hereby incorporated by reference.
- R C charged surface modifier
- the charge modifier (R C ) can have a surface coverage of between about 0.01 ⁇ mol/m 2 to about 10 ⁇ mol/m 2 . In some embodiments, the charge modifier (R C ) has a surface coverage of between about 0.02 ⁇ mol/m 2 to about 1 ⁇ mol/m 2 . In some embodiment, the the charge modifier (R C ) has a surface coverage of between about 0.1 ⁇ mol/m 2 to about 1 ⁇ mol/m 2 .
- an active coating having an alkylsilyl coating of Formula I with a charge modifier (R C ) that can result from coating # 3 of FIG. 2 is shown below.
- the final alkylsilyl coating shown below has multiple points for other charge modifiers (R C ) those points could also be C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, or a halo, as described herein.
- the final alkylsilyl coating shown below has multiple points for other charge modifiers (R C ) those points could also be a hydrophobicity modifier (R B ) and/or chelators or crown ethers.
- the charge modifiers (R C ) shown below can also be other points of attachment to the surface of the chromatographic flow path, i.e., R A .
- the alkysilyl coating with a charge modifier is combined with a hydrophobicity modifier (R B ).
- the hydrophobicity modifier can have a net neutral charge.
- zwitterionic modifiers such as carboxy- and sulfobetaine reagents.
- a zwitterionic modifier affords a macroscopically, net neutral surface, but also lends microscopic Coulombic effects that can be repulsive to a wide range of analytes, including those with diverse charge characteristics.
- the hydrophobicity modifier (R B ) can have a surface coverage between about 0.01 0.01 ⁇ mol/m 2 to about 10 ⁇ mol/m 2 . In some embodiments, the hydrophobicity modifier (R B ) has a surface coverage of between about 0.03 ⁇ mol/m 2 to about 0.9 ⁇ mol/m 2 . In some embodiments, the hydrophobicity modifier (R B ) has a surface coverage of between about 0.5 ⁇ mol/m 2 to about 3 ⁇ mol/m 2 .
- the hydrophobicity modifier (R B ) is attached to Formula I by a silyl ether moiety and has a composition selected the from one or more of the following:
- Z is independently selected from (C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I. Therefore, the hydrophobicity modifier is covalently bound to the alkylsilyl coating of Formula I by a silyl ether moiety.
- a corresponding hydrophobicity modifying reagent can be used to obtain the charge modifier of the final coating product, for example, the charge modifying reagent can be (3-glycidyloxypropyl)trimethoxysilane, hydrolyzed (3-glycidyloxypropyl)trimethoxysilane, n-decyltrichlorosilane, or N-(3-trimethoxysilylpropyl)gluconamide.
- coatings corresponding to exemplary embodiments of the technology are shown in FIG. 2 . These coatings include coatings having only a charge modifier (R C ), for example coating #s 1 and 3 , as well as coatings having both a charge modifier (R C ) and a hydrophobicity modifier (R B ), for example coating #s 2 , 4 , and 5 .
- R C charge modifier
- R B hydrophobicity modifier
- Hydrophobicity modifiers in combination with the charge modifiers, can be used to add a subtle, but well controlled secondary interaction. Molecules that might otherwise co-elute as a consequence of having near identical hydrophobicities can pass through, for example a frit coated with coating # 4 shown in FIG. 2 , where the molecule can experience subtle ion exchange partitioning when a gradient between water and acetonitrile based mobile phases are applied with acid modifiers of varying acidity, hydrophobicity, and ion pairing strength.
- Formic acid modified mobile phases are particularly useful in this regard as it does not attenuate electrostatic effects. This can be particularly useful when separating, for example, peptides, assays for citric acid cycle metabolites and glycans. Hydrophobicity modifiers, in combination with the charge modifiers, can also be used in hydrophilic interaction chromatography.
- an active coating having an alkylsilyl coating of Formula I with a charge modifier (R C ) and a hydrophobicity modifier (R B ) that can result from coating # 4 of FIG. 2 is shown below.
- the resulting coating shown below has multiple charge modifiers (R C ) any or all of those points could be a hydrophobicity modifier (R B ) or C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, or a halo or chelators or crown ethers, as described herein.
- the charge modifier (R C ) and a hydrophobicity modifier (R B ) need not be directly linked, for example, the charge modifier (R C ) and a hydrophobicity modifier (R B ) can be connected through one or more bridging silicon moieties with Y (as defined herein) chemical compositions.
- the alkysilyl coating with a charge modifier (R C ) is combined with an ion scavenging ligand, for example a chelator or crown ether.
- the chelator can be, for example, ethylenediaminetetraacetic acid or etidronic acid.
- the crown ether can be, for example, 18-crown-6, 12-crown-4, 15-crown-5, dibenzo-18-crown-6, or diaza-18-crown-6.
- the chelators and crown ethers can be attached covalently to a silanized/alkylsilyl coating, either through direct covalent attachment or through the use of secondary linker moieties.
- the chelators and crown ethers can scavenge ions, for example, Ca 2+ , Fe 3+ and/or K + that can be present in mobile phases, flow paths, and systems, which result in undesired gas phase ion adducts and cause the fouling and decommissioning of the mass spectrometer.
- the chelator or crown ether can pull metal ions out of the mobile phase to improve MS spectra.
- MS grade mobile phases will contain trace amounts of metal ions, such as sodium and potassium, and it is common for the quality of the mass spectra to suffer, as a result.
- a 50 ppb concentration of potassium can yield a 2 to 10% relative intensity of potassiated adduct ion.
- An active coating such as this can sequester these metal ions, ensuring they are not present in the chromatographic effluent upon ionization.
- mass spectra can be obtained with ion adduct signals below 2% relative intensity even when mobile phases with questionable purity are employed. This type of coating can be used prior to an injector and post column in the flow path.
- the chelator and crown ethers can be combined directly with the alkylsilyl coating of Formula I, without a charge modifier being present.
- the chelators and crown ethers can also be used in conjunction with the hydrophobicity modifiers described herein. In some embodiments, the chelators and crown ethers can be used in conjunction with both the charge modifiers and hydrophobicity modifiers described herein.
- a chromatographic device for separating analytes in a sample includes a sample injector having a sample injection needle for injecting the sample into the mobile phase, a sample reservoir container in fluid communication with the sample injector, a chromatography column downstream of the sample injector, the chromatography column having fluid connectors, and fluid conduits connecting the sample injector and the chromatography column. Interior surfaces of the fluid conduits, sample injector, sample reservoir container, and chromatography column form a fluidic flow path having wetted surfaces. At least a portion of the wetted surfaces of the fluidic flow path are coated with an alkylsilyl coating having the Formula I:
- each X is independently selected from (C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, OR A , R B , R C , R D and halo.
- R A represents a point of attachment to the interior surfaces of the fluidic system and at least one X is OR A .
- R B is absent or represents a hydrophobicity modifier.
- R C is absent or represents a charge modifier.
- R D represents a chelator, or a crown ether, and at least one X is R D .
- Y is a bridging moiety selected from (C 1 -C 20 )alkyl, —O[(CH 2 ) 2 O] 1-20 —, —(C 1 -C 10 )[NH(CO)NH(C 1 -C 10 )] 1-20 -, or —(C 1 -C 10 )[alkylphenyl(C 1 -C 10 )alkyl] 1-20 -.
- a chromatographic device for separating analytes in a sample includes a mobile phase reservoir, a mobile phase pump in communication with the mobile phase reservoir, a mobile phase inlet line have a first end in communication with the mobile phase reservoir and a second end in communication with the mobile phase pump, and a sinker at the first end of the mobile phase inlet line.
- Interior surfaces of the mobile phase reservoir, the mobile phase pump and the mobile phase inlet line form a fluidic flow path having wetted surfaces.
- Exterior surfaces of the sinker also have wetted surfaces, which are in contact with the mobile phase. At least a portion of the wetted surfaces in contact with the mobile phase are coated with an alkylsilyl coating having the Formula I:
- each X is independently selected from C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, OR A , R B , R C , R D , R E , and halo.
- R A represents a point of attachment to the interior surfaces of the fluidic system and at least one X is OR A .
- R B is absent or represents a hydrophobicity modifier.
- R C is absent or represents a charge modifier.
- R D is absent or represents a chelator, or a crown ether.
- R E is a bacteriostatic moiety, and at least one X is R E .
- Y is a bridging moiety selected from (C 1 -C 20 )alkyl, —O[(CH 2 ) 2 O] 1-20 —, —(C 1 -C 10 )[NH(CO)NH(C 1 -C 10 )] 1-20 -, or —(C 1 -C 10 )[alkylphenyl(C 1 -C 10 )alkyl] 1-20 -.
- the bacteriostatic moiety is a zwitterion.
- the zwitterionic coatings can be prepared by silanization with bis(trichlorosilyl)ethane followed by derivatization with N,N-(diethylaminopropyl)trimethoxysilane and subsequent reactions with chloro or bromo alkylcarboxylic acids.
- the bacteriostatic moiety is a quaternary amine.
- the bacteriostatic coating is applied to all components within the flow path including inlet filters, inlet mobile phase lines, pumps, transfer lines, sample syringes, frits and mobile phase containers (see, e.g., FIG. 1 ) to provide systemic protection against bacterial growth and premature column failure.
- the bacteriostatic moiety can be used alone, or in conjunction with a charge modifier, a hydrophobicity modifier and/or a chelator or crown ether.
- surfactants can be used as an active coating to solubilize proteins, including hydrophobic membrane proteins, and provide a denaturing environment that facilitates enzyme reactions, such as proteolysis and glycan release.
- a chromatographic device for separating analytes in a sample includes a sample injector having a sample injection needle for injecting the sample into the mobile phase, a sample reservoir container in fluid communication with the sample injector, a chromatography column downstream of the sample injector, the chromatography column having fluid connectors, and fluid conduits connecting the sample injector and the chromatography column. Interior surfaces of the fluid conduits, sample injector, sample reservoir container, and chromatography column form a fluidic flow path having wetted surfaces. At least a portion of the wetted surfaces of the fluidic flow path are coated with an alkylsilyl coating having the Formula I:
- each X is independently selected from (C 1 -C 6 )alkoxy, —NH(C 1 -C 6 )alkyl, —N((C 1 -C 6 )alkyl) 2 , OH, OR A , R B , R C , R D , R E , R F , and halo.
- R A represents a point of attachment to the interior surfaces of the fluidic system and at least one X is OR A .
- R B is absent or represents a hydrophobicity modifier.
- R C is absent or represents a charge modifier.
- R D is absent or represents a chelator, or a crown ether.
- R E is absent or represents a bacteriostatic moiety.
- R F represents a surfactant, and at least one X is R F .
- Y is a bridging moiety selected from (C 1 -C 20 )alkyl, —O[(CH 2 ) 2 O] 1-20 —, —(C 1 -C 10 )[NH(CO)NH(C 1 -C 10 )] 1-20 -, or —(C 1 -C 10 )[alkylphenyl(C 1 -C 10 )alkyl] 1-20 -.
- the surfactant (R F ) is sodium dodecyl sulfate, zwittergent 3-10 (Decyldimethylammonio)propanesulfonate, sodium deoxycholate, hexadecyl trimethyl ammonium bromide, triton, polysorbate, or a combination thereof.
- the devices and alkylsilyl coatings described herein can be used in chromatographic methods to separate analytes in a sample.
- the method includes introducing a sample including the analytes into a chromatographic system (e.g., a liquid chromatography system).
- the chromatographic system includes a flow path disposed in an interior of the chromatographic system where at least a portion of the flow path has an active coating.
- the chromatographic system also includes a chromatographic column that has a stationary phase material in an interior of the chromatographic column that facilitates separation of the analytes in the sample through interaction with at least one analyte in the sample.
- the chromatographic system can be the chromatographic system of FIG. 1 as described in detail herein.
- the active coating is selected to interact with at least one analyte in the sample.
- the interaction can be through repulsive forces, a secondary interaction, or a retention mechanism distinct from the interaction with the stationary phase material.
- the secondary interaction can be ion exchange partitioning.
- the analyte and the active coating can be negatively charged.
- the analyte and the active coating can be positively charged.
- the active coating repels the analyte and shields the analyte from interacting with the substrate (e.g., a metal chromatographic column or frit).
- the active coating can be applied to the flow path via vapor deposition.
- the active coating can be applied to a frit.
- the frit can be positioned at an inlet, an outlet or at both an inlet and outlet of the chromatographic column (see FIG. 1 ).
- the active coating can be any of the coating described herein.
- the technology includes a method of separating a sample comprising an anionic compound.
- the method includes introducing the sample comprising the anionic compound to a fluidic system including a flow path disposed in an interior of the fluidic system wherein at least a portion of the flow path includes an alkylsilyl coating of Formula I (as described herein) with a negatively-charged modifier.
- the sample is eluted through the fluidic system and the anionic compound is repelled by a negatively-charged modifier.
- the method also includes isolating the anionic compound.
- the anionic compound can be, for example, a nucleic acid or an oligonucleotide.
- the alkylsilyl coating can be, for example, coating # 1 shown in FIG.
- the method can be applied to samples comprising cations where the alkylsilyl coating of Formula I (as described herein) has a positively-charged modifier.
- the technology also includes a method of separating a sample comprising peptides.
- the method includes introducing the sample comprising the peptides into a chromatography column having a hydrophobic stationary phase disposed within the chromatography column and a frit at an outlet of the chromatography column.
- the hydrophobic stationary phase is a bridged ethylene hybrid C18 stationary phase.
- the frit is coated with an alkylsilyl coating of Formula I (as described herein) where the alkylsilyl coating has both a charge modifier and a hydrophobicity modifier.
- the charge modifier has a surface coverage of between about 0.03 ⁇ mol/m 2 to about 0.9 ⁇ mol/m 2 and the hydrophobicity modifier has a surface coverage of between about 0.5 ⁇ mol/m 2 to about 3 ⁇ mol/m 2 .
- the method also includes eluting the sample through the chromatography column and isolating the peptides.
- the charge modifier can be N,N-(diethylaminopropyl)silyl and the hydrophobicity modifier can be n-decyl silyl (i.e., coating # 4 in FIG. 2 ).
- the charge modifier, N,N-(diethylaminopropyl)silyl accounts for 10% of the surface coverage and the hydrophobicity modifier, n-decyl silyl, accounds for 90% of the surface coverage.
- Other ratios and percentages of surface coverage of the charge modifier and hydrophobicity modifier can be used.
- the peptides can be an Asp and iso ASP isomeric peptide pair.
- the method can also include partitioning the Asp and iso ASP isomeric peptide pair on the coated frit.
- the sample can include trypsinized immunoglobulin.
- the trypsinized immunoglobulin is trastuzumab.
- the technology also includes a method of separating a sample comprising proteins.
- the method includes introducing the sample comprising proteins into a chromatography column having a hydrophobic stationary phase disposed within the chromatography column and a frit at an inlet of the chromatography column.
- the hydrophobic stationary phase is a bridged ethylene hybrid C4 stationary phase.
- the frit is coated with an alkylsilyl coating of Formula I (as described herein) having a charge modifier with a surface coverage of between about about 0.1 ⁇ mol/m 2 to about 3 ⁇ mol/m 2 .
- the charge modifier is silyl propyl methyl phosphonate (i.e., coating # 1 in FIG. 2 ).
- the alkylsilyl coating used in this method does not have a hydrophobicity modifier.
- the method also includes eluting the sample through the chromatography column and isolating the proteins.
- the method can also include flowing a mobile phase having an ionic strength through the chromatography column such that the proteins are retained on the frit.
- the ionic strength of the mobile phase can be increased to displace a portion of the proteins from the frit.
- the method also includes eluting the displaced proteins through the chromatography column.
- the method includes coating flow paths prior to analyte introduction with a coating having a bactiostatic moiety as described herein.
- the flow path includes, for example, a mobile phase reservoir, mobile phase inlet lines, mobile phase pump, and a sinker.
- the bacteriostatic coating in included along portions or the entirety of the flow path of a chromatographic system.
- the method includes coating at least a portion of a flow path of a chromatographic system with a coating having a surfactant, as described herein.
- kits include a chromatographic components, for example, a chromatographic column, that has been coated with an alkylsilyl coating of Formula I, as described above.
- Other components can be provided in the kit that can also include the coatings described herein, for example, tubing, frits, and/or connectors.
- the kit can also include instructions for separating analytes, for example, biomolecules, proteins, glycans, peptides, oligonucleotides, pesticides, bisphosphonic acids, anionic or cationic compounds, and zwitterions like amino acids and neurotransmitters.
- FIG. 2 Coating # 1
- This coating can be constructed through silanization with bis(trichlorosilyl)ethane followed by trimethoxy silyl propyl methyl phosphonate.
- this flow path can confer an LC system that could be dedicated to the separation of certain analytes, such as nucleic acids or oligonucleotides.
- analytes such as nucleic acids or oligonucleotides.
- These types of analytes are polyanions and notoriously prone to adsorbing onto metal surfaces. It can be predicted that opposite charge compounds can adsorb to the coating in time and with routine sample injections. Nevertheless, it is believed that these adsorbed molecules will equilibrate to afford a surface that itself also exhibits low bind properties for the oligonucleotides. Because of this dynamic equilibrium, the surface charge must be deliberately selected and optimized.
- Example 2 Selectively Enhancing Coated Flow Path Components and Method for the Analysis of Citric Acid Cycle Metabolites and Asp/Iso Asp Peptide Isomers
- An active coating can be employed to enhance the selectivity of a separation.
- Many chromatographic applications are challenged to produce a separation between critical components, such as the acids of a citric acid cycle panel or the Asp/Iso Asp peptide isomers in an immunoglobulin proteolytic digest.
- a charge-modified, active coating can be combined with certain chromatographic modes and columns to achieve more effective, tailored separations.
- a surface modified with a basic, charge bearing moiety would be ideal for this application, such as a coating formed via silanization with bis(trichlorosilyl)ethane followed by a low coverage of N,N-(diethylaminopropyl)trimethoxysilane and high coverage of n-decyl trichlorosilane (i.e., FIG. 2 , Coating # 4 ).
- ideal coverage of N,N-(diethylaminopropyl)trimethoxysilane would correspond to 0.03 to 0.9 ⁇ mol/m 2 and ideal coverage for n-decyl trichlorosilane would correspond to 0.5 to 3 ⁇ mol/m 2 .
- a high surface area component of the flow path can be selected for use as a selectivity enhancer, lest its surface area be too insignificant to make a difference to the retentivity or selectivity of the overall separation apparatus.
- the frit of a liquid chromatography (LC) column housing can be modified to exhibit an active coating and advantageously used as a selectivity enhancer to add a subtle, yet well controlled secondary interaction.
- a 0.2 ⁇ m porosity stainless steel frit is modified with Coating # 4 of FIG. 2 and used in the outlet of an ACQUITY® UPLC® Peptide BEH C18 130 ⁇ 1.7 ⁇ m 2.1 ⁇ 150 mm column (commercially available from Waters Technologies Corporation, Milford, Mass.).
- this coated frit can be constructed into a column format with special design features amenable to the swapping and replacement of the high surface area selectivity enhancer.
- a sample of trypsinized immunoglobulin, such as trastuzumab gets loaded onto the column and then a gradient between water and acetonitrile based mobile phases is applied.
- Acid modifiers of varying acidity, hydrophobicity and ion pairing strength can be applied, though formic acid modified mobile phases are particularly attractive in that they do not attenuate electrostatic effects. Peptides that might co-elute as a consequence of having near identical hydrophobicities will pass through the selectivity enhancer wherein they will experience subtle ion exchange partitioning.
- the iso Asp containing species will be partitioned and thus be retained more extensively than the Asp containing species, given that an iso Asp residue is slightly more acidic (pKa 3.1 versus 3.9).
- This method is equally applicable to numerous other types of separations, including assays for citric acid cycle metabolites and glycans.
- an acidic, cation exchange selectivity enhancer can be employed.
- the selectivity enhancer can be used with hydrophilic interaction chromatography (HILIC).
- Example 3 Active Coating with Orthogonal Retentivity to Perform Multidimensional Chromatography
- an active coating with orthogonal retentivity to perform multidimensional chromatography can also be used to facilitate multidimensional chromatography.
- An active coating can also be used to facilitate multidimensional chromatography.
- a high surface area flow component like a frit, makes for a preferred substrate.
- this active coating is intended for this active coating to strongly retain a class of analytes by a retention mechanism that is orthogonal to that of the implemented LC column.
- this coating can be implemented at any location in the flow path, it is advantageous to consider it being incorporated at the head (inlet) of the column.
- Analytes adsorb to this flow path component, are eluted to a downstream LC column in a gradient or set of discrete mobile phase changes and secondary gradients across the packed bed of the LC column are thereafter performed.
- a surface modified with a strongly acidic, charge bearing moiety would be ideal for this application, such as a coating formed via silanization with bis(trichlorosilyl)ethane followed by trimethoxy silyl propyl methyl phosphonate.
- ideal coverage for trimethoxy silyl propyl methyl phosphonate would correspond to 0.1 to 3 ⁇ mol/m 2 .
- a 0.2 ⁇ m porosity stainless steel frit is modified with a version of Coating # 1 of FIG. 2 having a high coverage of trimethoxy silyl propyl methyl phosphonate (2 ⁇ mol/m 2 ) and is used in the inlet of an ACQUITY® UPLC® Peptide BEH C18 130 ⁇ 1.7 ⁇ m 2.1 ⁇ 150 mm column (commercially available from Waters Technologies Corporation, Milford, Mass.).
- a proteolyzed protein sample gets loaded onto the column under aqueous, low ionic strength conditions. By way of cation exchange, the peptides are thus retained on the inlet frit.
- An increase in mobile phase ionic strength can then be employed to displace a subset of the peptides (the least basic) onto the packed bed of the LC column.
- a gradient between water and acetonitrile is thereafter applied to elute the displaced peptides and thereby obtain a second dimension chromatogram.
- This process is continued with steps of increasing ionic strength until the entirety of the sample is profiled.
- this method is equally applicable to numerous other types of separations and analytes, not only peptides and proteolyzed proteins. It is also applicable to use with a HILIC LC column.
- a coated flow path component can be modified to bear ion scavenging ligands, such as chelators or crown ethers.
- ion scavenging ligands such as chelators or crown ethers.
- a number of chemical compounds show a capacity to sequester metal ions, whether they be alkali, alkaline earth and transition metals.
- Chelators such as ethylenediaminetetraacetic acid and etidronic acid, are ubiquitously used in solutions to scavenge Ca 2+ and Fe3+.
- crown ethers can be used to selectively coordinate certain cations with high affinity. 18-crown-6, for instance, is widely recognized for its high affinity for potassium (K + ) ions.
- these ligands can be attached covalently to a silanized/alkylsilyl coating, either through direct covalent attachment or through the use of secondary linker moieties.
- a 0.2 ⁇ m porosity stainless steel frit is modified with bis(trichlorosilyl)ethane coating, which is then subsequently derivatized with a crown ether, including but not limited to 18-crown-6, 12-crown-4, 15-crown-5, dibenzo-18-crown-6, and diaza-18-crown-6.
- This frit can be used as the outlet of an LC column or in a separate vessel to scavenge for impurity metal cations that might be present in mobile phases or leaching from an instrument flow path.
- An active coating devised to be a bacteriostatic agent represents an ideal solution because the agents can be applied to all components within the flow path including inlet filters, inlet mobile phase lines, pumps, transfer lines, sample syringes, frits and mobile phase containers (see, e.g., FIG. 1 ) to provide systemic protection against bacterial growth and premature column failure.
- zwitterionic coatings can be prepared by silanization with bis(trichlorosilyl)ethane followed by derivatization with N,N-(diethylaminopropyl)trimethoxysilane and subsequent reactions with chloro or bromo alkylcarboxylic acids.
- Quaternary amines have been shown to have potent antimicrobial activity and can be applied to the surface of frits or degasser lines to reduce or eliminate growth thus avoiding premature column failure. While not limited to theory, it is believed that quaternary amine and zwitterion containing active coatings disrupt the formation lipid bilayers and thereby interfere in an integral mechanism of biological growth.
- bacteriostatic coatings are employed in regions prior to analyte injection, for example, sinkers and mobile phase inlet lines.
- surfactants are used to solubilize proteins, including hydrophobic membrane proteins, and provide a denaturing environment that facilitates enzyme reactions, such as proteolysis and glycan release.
- enzyme reactions such as proteolysis and glycan release.
- ionic surfactants in LC/MS analysis is discouraged due to the reduction of analyte signal observed because of the highly charged nature of the surfactant. This problem can be alleviated by the use of surfactants that are tethered to a device (or coated on a device) and not prone to release into the MS system.
- surfactant moieties with desirable properties include, but are not limited to, sodium dodecyl sulfate, zwittergent 3-10 (Decyldimethylammonio)propanesulfonate, sodium deoxycholate, hexadecyl trimethyl ammonium bromide, triton and polysorbate.
- chaotropic moieties can be incorporated into the active coating and can consist of chemical structures with chemical similarity to guanidine and urea. In each of these examples, the active coating will induce the denaturation of a protein analyte through manipulating its entropically driven, hydration based folding.
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
Description
- This application claims priority to and benefit of U.S. provisional patent application No. 62/811,029 filed on Feb. 27, 2019 and entitled “Coated Flow Path Components for Chromatographic Effects,” the entire contents of which is hereby incorporated by reference.
- The present disclosure relates to methods of separating an analyte(s) from a sample. More particularly, the present disclosure relates to active coatings that are vapor deposited onto at least a portion of a flow path (wetted surfaces) of a chromatographic system to interact with at least one analyte in the sample through a repulsive force, a secondary interaction, or a retention mechanism distinct from the interaction with the stationary phase material.
- Analytes that interact with metal have often proven to be very challenging to separate. The desire to have high pressure capable chromatographic systems with minimal dispersion has required that flow paths decrease in diameter and be able to withstand increasingly high pressures at increasingly fast flow rates. As a result, the material of choice for chromatographic flow paths is often metallic in nature. This is despite the fact that characteristics of certain analytes, for example, biomolecules, proteins, glycans, peptides, oligonucleotides, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and neurotransmitters, are known to have unfavorable interactions, so called chromatographic secondary interactions, with metallic surfaces.
- The proposed mechanism for metal specific binding interactions requires an understanding of Lewis theory of acid-base chemistry. Pure metals and metal alloys (along with their corresponding oxide layers) have terminal metal atoms that have characteristics of a Lewis acid. More simple, these metal atoms shown a propensity to accept donor electrons. This propensity is even more pronounced with any surface metal ions bearing a positive charge. Analytes with sufficient Lewis base characteristics (any substance that can donate non-bonding electrons) can potentially adsorb to these sites and thus form problematic non-covalent complexes. It is these substances that are defined as metal-interacting analytes.
- For example, analytes having phosphate groups are excellent polydentate ligands capable of high affinity metal chelation. This interaction causes phosphorylated species to bind to the flow path metals thus reducing the detected amounts of such species, a particularly troublesome effect given that phosphorylated species are frequently the most important analytes of an assay.
- Other characteristics of analytes can likewise pose problems. For example, carboxylate groups also have the ability to chelate to metals, albeit with lower affinities than phosphate groups. Yet, carboxylate functional groups are ubiquitous in, for example, biomolecules, giving the opportunity for cumulative polydentate-based adsorptive losses. These complications can exist not only on peptides and proteins, but also glycans. For example, N-glycan species can at times contain one or more phosphate groups as well as one or more carboxylate containing sialic acid residues. Additionally, smaller biomolecules such as nucleotides and saccharides, like sugar phosphates, can exhibit similar behavior to the previously mentioned N-glycan molecules. Moreover, chromatographic secondary interactions can be especially problematic with biomolecules, particularly larger structures, because they have a capacity (via their size and structural order) to form microenvironments that can adversely interact with separation components and flow path surfaces. In this case, a biomolecule or analyte having larger structures, can present structural regions with chemical properties that amplify a secondary interaction to the material of a flow path. This, combined with the cumulative metal chelation effects curtails the overall effective separation of biomolecules, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and meurotransmitters.
- An alternative to using metal flow paths is to use flow paths constructed from polymeric materials, such a polyether ether ketone (PEEK). PEEK tubing, like most polymeric materials, is formed by means of an extrusion process. With polymeric resin, this manufacturing process can lead to highly variable internal diameters. Accordingly, PEEK column hardware yields unfavorable differences in the retention times as can be observed from switching between one column and the next. Often, this variation can be a factor of three higher than a metal constructed column. In addition, the techniques for fabricating polymer based frits are not yet sufficiently optimized to afford suitably rugged components for commercial HPLC columns. For example, commercially available PEEK frits tend to exhibit unacceptably low permeability.
- Ongoing efforts to reduce chelation and unwanted secondary chromatographic interactions of analytes with metal (or other) chromatographic surfaces in an effort to facilitate chromatographic separation having higher resolutions are therefore needed.
- One solution to reducing unwanted secondary chromatographic interactions of analytes with metal (or other) chromatographic surfaces is to use an alkylsilyl coating to minimize interactions between analytes of the metal flow path (making the flow path inert to the analytes of interest) as detailed in U.S. patent application Ser. No. 16/133,089 filed on Sep. 17, 2018.
- As described here, it is also beneficial to modify flow path components with an organosilica functionality that exhibits chemical properties that have an effect on the chromatographic separation. These so-called ‘active’ coatings can introduce a Coulombic repulsive effect with an analyte to shield them from interacting with the substrate material (e.g., metal, plastic, etc.) of the flow path in a way that negatively affects the chromatographic separation. In addition, an ‘active’ coating can be produced that adds an enhancing selectivity to a separation by way of a subtle secondary interaction. Moreover, an ‘active’ coating can be prepared that affords an entirely orthogonal retention mechanism, which facilitates the adsorption, partitioning, and desorption of analytes in a process distinct from that achieved with the stationary phase of a column.
- The present disclosure provides a number of advantages over current systems and methodology. For example, the technology of the present disclosure not only reduces unwanted interactions between analytes and metallic or polymeric surfaces, but modifies the surfaces of a chromatographic flow path in such a way as to positively affect the separation, for example, by enhancing selectivity. In this way, the chromatographic separation can be effected and enhanced not just by the chromatographic stationary phase material but also by other chromatographic surfaces that interact with the analytes.
- In one aspect, the technology relates to a method of separating analytes in a sample. The method includes introducing a sample comprising the analytes into a chromatographic system. The chromatographic system includes a flow path disposed in an interior of the chromatographic system where at least a portion of the flow path having an active coating, and a chromatographic column having a stationary phase material in an interior of the chromatographic column that facilitates separation of the analytes in the sample through interaction with at least one analyte in the sample. The active coating is selected to interact with at least one analyte in the sample through (1) a repulsive force, (2) a secondary interaction, or (3) a retention mechanism distinct from the interaction with the stationary phase material. The method can include one or more of the embodiments described herein.
- In some embodiments, the analyte and the active coating are negatively charged. The analyte and active coating can be positively charged.
- In some embodiments, the active coating is applied to the flow path by vapor deposition. The active coating can be applied to a frit. The frit can be positioned at an outlet of the chromatographic column. In some embodiments, the frit is positioned at an inlet of the chromatographic column. The chromatographic column can have two frits, one positioned at the outlet of the chromatographic column and one positioned at the inlet of the chromatographic column.
- In some embodiments, the secondary interaction is ion exchange partitioning.
- In another aspect, the technology relates to a chromatographic device for separating analytes in a sample. The device includes a sample injector having a sample injection needle for injecting the sample into the mobile phase, a sample reservoir container in fluid communication with the sample injector, a chromatography column downstream of the sample injector, the chromatography column having fluid connectors, and fluid conduits connecting the sample injector and the chromatography column. In some embodiments, the fluid connectors are connect post-column detector(s) and devices. Interior surfaces of the fluid conduits, sample injector, sample reservoir container, and chromatography column form a fluidic flow path having wetted surfaces. At least a portion of the wetted surfaces of the fluidic flow path are coated with an alkylsilyl coating having the Formula I:
- Each X is independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, RB, RC, RD and halo. RA represents a point of attachment to the interior surfaces of the fluidic system and at least one X is ORA. RB is absent or represents a hydrophobicity modifier. RC represents a charge modifier and at least one X is RC. RD is absent, a chelator, or a crown ether. Y is a bridging moiety selected from (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20-, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. The device can include one or more of the embodiments described herein.
- In some embodiments, the charge modifier has the same charge as at least one analyte in the sample. The charge modifier (RC) can be attached to Formula I by a silyl ether moiety and has a composition selected from the group consisting of n-cyclohexylaminomethyl silyl , n-(2-aminoethyl)-3-aminopropyl silyl , n-cyclohexyl-3-aminopropyl silyl, n-(2-aminoethyl)-3-aminopropylmethyl silyl, n-cyclohexylaminomethyl silyl, bis (silylpropyl)-n-methylamine, 3-aminopropyl diisopropyl silyl, (3-aminopropyl) silyl, n,n-diethyl-3-aminopropyl silyl, propanesulfonic acid silyl, N-(hydroxyethyl)-N,N-bis(silyl propyl)amine, 2-(4-pyridylethyl) silyl, tris (silylmethyl) amine, carboxyethyl silyl , and silyl propyl methyl phosphonate.
- In some embodiments, the charge modifier (RC) is
- Z is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- In some embodiments, the charge modifier (RC) is
- Z is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- In some embodiments, the charge modifier (RC) is a quaternary amine.
- The alkylsilyl coating of Formula I can be at least 100 Å thick. In some embodiments, the charge modifier (RC) has a surface coverage between about 0.01 μmol/m2 and about 10 μmol/m2. The charge modifier (RC) can have a surface coverage between about 0.02 μmol/m2 and about 1 μmol/m2.
- In some embodiments, the hydrophobicity modifier (RB) is present. The hydrophobicity modifier (RB) can have a net neutral charge. The hydrophobicity modifier (RB) can be attached to Formula I by a silyl ether moiety and can have a composition selected from the group consisting of n-decyl silyl, trimethyl silyl, n-propyl silyl, t-butyl dimethyl silyl, 4-phenylbutyl silyl, n-octadecyl diisobutyl silyl, 6-phenylhexyl silyl, n-octadecyl silyl, n-methyl-O-methyl carbamate silyl, phenyl silyl, diphenyl methyl silyl, sulfobetaine silyl, carboxybetaine silyl, glycidoxy propyl silyl, hydrolyzed glycidoxypropyl silyl, and N-(propyl) gluconamide silyl.
- In some embodiments, the hydrophobicity modifier (RB) is
- Z is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- In some embodiments, the hydrophobicity modifier (RB) is
- Z is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- In some embodiments, the alkylsilyl coating of Formula I is
- at least one X is the charge modifier (RC), wherein RC is
- and at least one X is the hydrophobicity modifier (RB), wherein RB is
- Z is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- In some embodiments, the alkylsilyl coating of Formula I is
- at least one X is the charge modifier (RC), wherein RC is
- and at least one X is the hydrophobicity modifier (RB), wherein RB is
- Z is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- In some embodiments, the alkylsilyl coating of Formula I is
- at least one X is the charge modifier (RC), wherein RC is
- and at least one X is the hydrophobicity modifier (RB), wherein RB is
- Z is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I.
- In some embodiments, the hydrophobicity modifier (RB) has a surface coverage between about 0.01 μmol/m2 and about 10 μmol/m2. The hydrophobicity modifier (RB) can have a surface coverage between about 0.03 μmol/m2 and about 0.9 μmol/m2. In some embodiments, the hydrophobicity modifier has a surface coverage between about 0.5 μmol/m2 and about 3 μmol/m2.
- The chromatography column can include a frit having a wetted surface coated with the alkylsilyl coating of Formula I. The frit can be positioned at an outlet of the chromatography column. In some embodiments, the frit is positioned at an inlet of the chromatography column. The chromatographic column can have two fits, one positioned at the outlet of the chromatographic column and one positioned at the inlet of the chromatographic column
- In some embodiments, the hydrophobicity modifier (RB) is present.
- The device can also include a detector downstream of the chromatography column, wherein the fluidic flow path further comprises the detector. The detector can be a mass spectrometer and the fluidic flow path include wetted surfaces of an electrospray needle.
- In some embodiments, RD is present. RD can be the chelator and the chelator can be ethylenediaminetetraacetic acid. In some embodiments, RD is the chelator and the chelator is etidronic acid. RD can be the crown ether and the crown ether can be selected from the group consisting of 18-crown-6, 12-crown-4, 15-crown-5, dibenzo-18-crown-6, and diaza-18-crown-6.
- In another aspect, the technology features a method of separating a sample comprising an anionic compound. The method includes introducing the sample comprising the anionic compound to a fluidic system including a flow path disposed in an interior of the fluidic system, wherein at least a portion of the flow path comprising an alkylsilyl coating having the Formula I:
- Each X is independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, RB, RC, RD and halo. RA represents a point of attachment to the interior surfaces of the fluidic system and at least one X is ORA. RB is absent or represents a hydrophobicity modifier. RC represents a negatively-charged modifier and at least one X is RC. RD is absent, a chelator, or a crown ether. Y is a bridging moiety selected from (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20-, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. The method also includes eluting the sample through the fluidic system, wherein the anionic compound is repelled by the negatively-charged modifier (RC), and isolating the anionic compound. The method can include one or more of the embodiments described herein.
- In some embodiments, the anionic compound is a nucleic acid. The anionic compound can be an oligonucleotide.
- In some embodiments, the alkylsilyl coating of Formula I is
- and the negatively-charged modifier (RC) is
- In another aspect, the technology features a method of separating a sample comprising peptides. The method includes introducing the sample comprising peptides into a chromatography column having a hydrophobic stationary phase disposed within the chromatography column and a frit at an outlet of the chromatography column, wherein the frit is coated with an alkylsilyl coating having the Formula I:
- Each X is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, RB, RC, RD and halo. RA represents a point of attachment to the interior surfaces of the fluidic system and at least one X is ORA. RB represents a hydrophobicity modifier and at least one X is RB. RC represents a charge modifier and at least one X is RC. Y is a bridging moiety selected from (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20-, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. The charge modifier has a surface coverage of between about 0.03 μmol/m2 to about 0.9 μmol/m2 and the hydrophobicity modifier has a surface coverage of between about 0.5 μmol/m2 to about 3 μmol/m2. The method also includes eluting the sample through the chromatography column and isolating the peptides. The method can include one or more of the embodiments described herein.
- In some embodiments, the charge modifier is N,N-(diethylaminopropyl)silyl. The hydrophobicity modifier can be n-decyl silyl.
- In some embodiments, the peptides include Asp and iso ASP isomeric peptide pair. The method can also include partitioning the Asp and iso ASP isomeric peptide pair on the coated frit.
- In some embodiments, the hydrophobic stationary phase comprises a bridged ethylene hybrid C18 stationary phase.
- The sample can include trypsinized immunoglobulin. In some embodiments, the trypsinized immunoglobulin is trastuzumab.
- In another aspect, the technology includes a method of separating a sample comprising proteins. The method includes introducing the sample comprising proteins into a chromatography column having a hydrophobic stationary phase disposed within the chromatography column and a frit at an inlet of the chromatography column, wherein the frit is coated with an alkylsilyl coating having the Formula I:
- Each X is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, RB, RC, RD and halo. RA represents a point of attachment to the interior surfaces of the fluidic system and at least one X is ORA. RC represents a charge modifier and at least one X is RC. Y is a bridging moiety selected from (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20-, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. The charge modifier has a surface coverage of between about 0.1 μmol/m2 to about 3 μmol/m2. The method also includes eluting the sample through the chromatography column, and isolating the proteins. The method can include one or more of the embodiments described herein.
- In some embodiments, the hydrophobic stationary phase includes a bridged ethylene hybrid C4 stationary phase. The charge modifier can be silyl propyl methyl phosphonate.
- The method can also include flowing a mobile phase having an ionic strength through the chromatography column such that the proteins are retained on the frit, increasing the ionic strength of the mobile phase to displace a portion of the proteins from the frit, and eluting the displaced proteins through the chromatography column.
- The features illustrated or described in connection with one aspect and/or embodiment can be combined with the features of other aspects and/or embodiments. Such modifications and variations are intended to be included within the scope of the present invention.
- The technology will be more fully understood from the following detailed description taken in conjunction with the accompanying drawings, in which:
-
FIG. 1 is a schematic of a chromatographic flow system including a chromatography column and various other components, in accordance with an illustrative embodiment of the technology. A fluid is carried through the chromatographic flow system with a fluidic flow path extending from a fluid manager to a detector. -
FIG. 2 is a chart showing exemplary embodiments of coatings, in accordance with an illustrative embodiment of the technology. - It is critical in liquid chromatography for flow paths and their chemical properties to be given serious consideration. Generally, it is advantageous while designing a flow path to make it inert to sample analytes, given that it is preferred for it to not be of any influence to a separation. Low-bind surfaces are accordingly garnering attention, including organosilica coatings such as those deposited by vapor phase reactions (see, e.g., U.S. patent application Ser. No. 16/133,089 filed on Sep. 17, 2018). Contrary to these inert, low-bind surfaces, the technology described herein relates to ‘active’ coatings, i.e., coatings that influence a separation. Flow path components for liquid chromatography can be modified with an organosilica (alkylsilyl) functionality to purposefully exhibit chemical properties of effect to a chromatographic separation. An ‘active’ coating such as this can introduce a Coulombic repulsive effect with an analyte to shield the analyte from interacting with the substrate material of the flow path. In addition, an ‘active’ coating can be produced that adds an enhancing selectivity to a separation by way of a secondary interaction. Moreover, an ‘active’ coating can be prepared that affords an entirely orthogonal retention mechanism, which facilitates the adsorption, partitioning, and desorption of analytes in a process, distinct from that achieved with the stationary phase of a column.
- Coatings suitable for achieving these chromatographic effects can be constructed by numerous means. Organosilica (alkylsilyl) is a versatile composition to use in the coating of both metallic and polymeric flow path components, which can range from an injector needle and pre-column heater to post-column tubing, column housings, frits, detector flow cells, and electrospray needles. The organosilica (alkyksilyl) coating can be applied via either gas phase or solution phase reactions and with a host of different silanizing reagents. For example, an alkylsilyl coating can be applied via vapor deposition, which can then be deliberately doped with a charged surface modifier.
- In general, a number of aspects of the technology are directed to (1) devices having an alkylsilyl ‘active’ coating; (2) methods of isolating an analyte in a sample, in particular a metal-interacting analyte; and (3) kits comprising various chromatographic components coated with an alkylsilyl ‘active’ coating and instructions for use. In some aspects, a coating is used to modify a flow path to address flow path interactions with an analyte and to interact with the analyte so that the chromatographic separation is improved, for example, increasing selectivity of the analyte of interest. That is, the active coating minimizes surface reactions with the metal interacting analyte while at the same time interacting with the analyte to improve separations. The reduction/elimination of the interactions between the analyte and the metal is advantageous because it allows for accurate quantification and analysis of a sample containing a metal-interacting analyte, for example, biomolecules, proteins, glycans, peptides, oligonucleotides, pesticides, bisphosphonic acids, anionic metabolites, and zwitterions like amino acids and neurotransmitters. The biomolecule can be selected from a peptide or peptide fragment, an oligopeptide, a protein, a glycan, a nucleic acid or nucleic acid fragment, a growth factor, a carbohydrate, a fatty acid, and a lipid. In one aspect, the biomolecule is a protein, a peptide, or a glycan. The biomolecule can be a phosphoglycan or a phosphopeptide.
- In addition to reducing/eliminating the interactions between the analyte and the metal, the ‘active’ coating has further advantages in that the coating interacts with the analyte to improve separations. The active coating can improve separations by, for example, actively repelling the analyte from the metallic surfaces, introducing a secondary interaction between the coating and the analyte that enhances selectivity, and/or provides an orthogonal retention mechanism that is different from the retention mechanism of the stationary phase material.
- In the present technology, vapor deposited alkylsilyl coatings on wetted surfaces of fluidic systems (e.g., liquid chromatography systems) modify the fluidic flow path to introduce an interaction between the alkylsilyl coating and the analyte(s). As such, they are ‘active’ coatings (meaning that the analyte(s) of the sample interact with the alkylsilyl coating).
- Devices
-
FIG. 1 is a representative schematic of a chromatographic flow system/device 100 that can be used to separate analytes in a sample.Chromatographic flow system 100 includes several components including a fluid manager system 105 (e.g., controls mobile phase flow through the system), tubing 110 (which could also be replaced or used together with microfabricated fluid conduits), fluid connectors 115 (e.g., fluidic caps), frits 120, achromatography column 125, asample injector 135 including a sample injection needle (not shown) to insert or inject the sample into the mobile phase, a vial, sinker, orsample reservoir 130 for holding the sample prior to injection, adetector 150 located downstream of thechromatography column 125, and apressure regulator 140 for controlling pressure of the flow. Thesample reservoir 130 is in fluid communication with the sample injection needle. Interior surfaces of the components of the chromatographic system/device form a fluidic flow path that has wetted surfaces. The fluidic flow path can have a length to diameter ratio of at least 20, at least 25, at least 30, at least 35 or at least 40. - The fluidic flow path can include the
detector 150. Thedetector 150, can be a mass spectrometer. The fluidic flow path can include wetted surfaces of an electrospray needle (not shown). - At least a portion of the wetted surfaces can be coated with an alkyl silyl coating, described in detail herein, selected to interact with the analyte(s) in the sample to improve the separation of the analyte(s) in the sample. The coating can be applied by vapor deposition. As such, methods and devices of the present technology provide the advantage of being able to use high pressure resistant materials (e.g., stainless steel) for the creation of the flow system, but also being able to tailor the wetted surfaces of the fluidic flow path to provide selected interactions between the alkylsilyl coating and the analyte(s) of interest to improve separation.
- The alkylsilyl coating can be provided throughout the system from the tubing or
fluid conduits 110 extending from thefluid manager system 105 all the way through to thedetector 150. The coatings can also be applied to portions of the fluidic fluid path. That is, one may choose to coat one or more components or portions of a component and not the entire fluidic path. For example, the internal portions of thecolumn 125 and itsfrits 120 and endcaps 115 can be coated whereas the remainder of the flow path can be left unmodified. Further, removable/replaceable components can be coated. For example, the vial orsinker 130 containing the sample reservoir can be coated as well asfrits 120. - In some embodiments, one or both
frits 120 have a wetted surface that is coated with one of the alkylsilyl coatings described in detail herein (for example the coatings shown inFIG. 2 ). A frit 120 can be positioned at the inlet or outlet of thecolumn 125. In some embodiments, thecolumn 125 has a frit 120 positioned at both the inlet and outlet of thecolumn 125. In some embodiments, thechromatographic column 125 can be designed such that the inlet and/oroutlet frit 120 is replaceable. In this way, if thefrit 120 is coated with an alkyl silyl coating described herein, thefrit 120 can be easily replaced with a frit having a different alkyl silyl coating to achieve a different effect. - In one aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of tubing. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of microfabricated fluid conduits. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of a column. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by passageways through a frit. In another aspect, the flow path of the fluidic systems described herein is defined at least in part by an interior surface of a sample injection needle. In another aspect, the flow path of the fluidic systems described herein extends from the interior surface of a sample injection needle throughout the interior surface of a column. In another aspect, the flow path extends from a sample reservoir container (e.g. sinker) disposed upstream of and in fluidic communication with the interior surface of a sample injection needle throughout the fluidic system to a connector/port to a detector.
- In some embodiments, only the wetted surfaces of the chromatographic column and the components located upstream of the chromatographic column are coated with the alkylsilyl coatings described herein while wetted surfaces located downstream of the column are not coated. The coating can be applied to the wetted surfaces via vapor deposition.
- At least a portion of the wetted surfaces of the fluidic flow path are coated with an alkylsilyl coating having Formula I:
- Each X is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, RB, RC, RD and halo. In some embodiments, X is independently selected from ORA, RB, RC, and RD. C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, and halo are reactive/hydrolysable groups. In some embodiments, these groups provide residual reactive groups where amino>halo>alkoxy as it relates to silane reactivity. In some embodiments, the specific coating that is used (e.g., the specific selection of X in Formula I) depends on the type of chromatographic separation being performed. The goal is to create chemically stable (good longevity) coatings on various materials present in a chromatographic flow path. However, hydrophilic coatings have no interactions in reversed phase liquid chromatography, while hydrophilic coatings can exhibit some retention in hydrophilic interaction chromatography. While one coating may suffice for multiple different chemical separations, different coatings can also be used for different modes of liquid chromatography.
- RA represents a point of attachment to the interior surfaces of the fluidic system and at least one X is ORA. RB is absent or represents a hydrophobicity modifier. RC represents a charge modifier and at least one X is RC. RD is absent, a chelator, or a crown ether. Y is a bridging moiety selected from (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20-, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-. The selection of Y can be dictated by both chemical and physical consideration. While not being limited by theory, short alkyl chains can produce more rigid, mechanically stronger substrates. However, alkyl bridging (Y) groups can yield materials with significant hydrophobicity. Accordingly, heteroatom containing Y groups can be employed. Furthermore, phenyl/aromatic groups can be used to introduce pi electrons that alter the electrostatic density and adsorption properties of the substrate.
- Therefore, the alkylsilyl coating of Formula I has at least one X that is ORA, a point of attachment to the interior surfaces of the fluidic system and at least one X that is RC, which represents a charge modifier. The hydrophobicity modifier RB and the chelator or crown ether RD can be absent. In some embodiments, the alkylsilyl coating of Formula I has a charge modifier. In some embodiments, the alkylsilyl coating of Formula I has a charge modifier and a hydrophobicity modifier. In some embodiments, the alkylsilyl coating of Formula I has a charge modifier and a chelator or crown ether. In some embodiments, the alkylsilyl coating of Formula I has a charge modifier, a hydrophobicity modifier and a chelator or crown ether.
- In other embodiments, the alkylsilyl coating of Formula I has at least one X that is ORA, a point of attachment to the interior surfaces of the fluidic system and at least one X that is RC, which represents a chelator or crown ether. In some embodiments, the alkylsilyl coating of Formula I has a chelator or crown ether and a hydrophobicity modifier.
- When used in the context of a chemical formula, a hyphen (“-”) indicates the point of attachment. For example, when Y is —[(C1-C10)alkylphenyl(C1-C10)alkyl]1-20-, that means that Y is connected to one SiX3 via the (C1-C10)alkyl and connected to the other SiX3 via the other (C1-C10)alkyl. This applies to the remaining variables.
- In one embodiment, Y in Formula I is (C1-C15)alkyl, (C1-C12)alkyl, or (C1-C10)alkyl. In some embodiments, Y in Formula I is methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, iso-butyl, t-butyl, pentyl, hexyl, heptyl, nonyl, or decanyl. In other aspect, Y in Formula I is ethyl or decanyl.
- In some embodiments, X can be another Y bridging moiety. In this way, the alkylsilyl coating can have more than two Si atoms bridged by two separated Y bridging moieties. When multiple Y bridging moieties are in the alkyl silyl coating, the Y bridging moieties can be the same Y moiety or different Y moieties. Multiple bridging moieties can result in the alkylsily coating being in a straight chain or branched. In addition, an alkylsilyl coating having multiple Y bridging moieties can be hyper-crosslinked with extensive bridging. The first bridging alkylsilyl composition can be highly crosslinked with some surface heterogeneity and mix of bridging moieties and silanols. That surface can then be modified with one or more of the modifiers described herein (e.g., charge modifiers, hydrophobicity modifiers, chelators and/or crown ethers, or surfactants).
- In some embodiments, the active alkylsilyl coating is comprised at least in part by Formula I as described herein. In that way, the alkylsilyl coating of Formula I is at least a portion of the coating. The coating could have other Y bridging moieties with multiple modifiers as described herein.
- Moreover, when the active alkylsilyl coatings described herein have multiple Y bridging moieties, the coating can be tailored to provide different microporosities and densities. Temperatures, vapor concentrations, and rates of deposition or hydrolysis can be adjusted to alter the porosity, density and thickness of the coating. Denser coatings are advantageous for minimizing ion and liquid transfer. Denser coatings are preferred to mitigate corrosion and to limit long distance interactions between analytes and flow path substrates.
- Generally, a bridging silane reagent is first applied to wetted surfaces of the fluidic flow path via vapor deposition to achieve a high build, e.g., greater than about 100 Å thick base layer, resulting in Formula I once deposited onto the wetted surfaces of the fluidic flow path. For example, the thickness can be between about 100 Å to about 1600 Å. The thickness of the coating can be about 100 Å, 200 Å, 300 Å, 400 Å, 500 Å, 600 Å, 700 Å, 800 Å, 900 Å, 1000 Å, 1100 Å, 1200 Å, 1300 Å, 1400 Å, 1500 Å, or 1600 Å. The reagent can be, for example, bis(trichlorosilyl)ethane, bis(3-trimethoxysilylpropyl)-N-methylamine, 1,4-bis(methoxydimethylsilyl)benzene, bis(trimethoxysilylethyl)benzene, 1,8-bis(triethyoxysilyl)octane, or 1,4-bis(triethyoxysilyl)benzene.
- In some embodiments a single modifier is used, for example, a single charge modifier. In other embodiment, multiple modifiers are used, for example, multiple charge modifiers or combinations or charge modifiers and hydrophobicity modifiers.
- Onto a suitable base layer, a charge modifying salinizing reagent can be applied. These charge bearing surface modifiers are comprised of strong acids/bases or weak acids/bases with a dissociation constant selected in a desirable range of pKa and can include but are not limited to trimethoxy silyl propyl methyl phosphonate and N,N-(diethylaminopropyl) trimethoxysilane. Strong acids can be desirable in some applications and be selected to have a pKa from about −2 to about 2, while other applications are more desirable with week acids have a pKa from about 2 to about 7. Other applications can benefit from weak bases have a pKa from about 7 to 11, while some applications can benefit from strong bases having a pKa from about 11 to about 14. Having surface modification with some pKa (rather than permanent charge) provides an opportunity to discharge the modified surface by pH. This allows the surface to regenerate by simple wash. Alternatively, if the charge is permanent, there is a possibility for retention of sample components of the opposite charge and such contaminants can accumulate on the charged surface and can be difficult to get rid of. By having an option to discharge the surface with pH and remove contaminants retained by charge, the robustness of the analysis can be improved.
- Surface modifiers with fixed charges, such as quaternary amines, can also be employed. These surface modifiers can be incorporated in situ during a vapor deposition process or through secondary, liquid phase reactions that are broadly employed by those skilled in the art. In some embodiments, liquid phase reactions can include multiple steps so as to build the desired charge modifying moiety. For example for separation of nucleic acids or phosphopeptides that are negatively charged, the surface charge can be negative. In such case, the analytes are repelled from the surface and have no losses due to non-specific adsorption.
- The charge modifier (RC) can have the same charge as at least one analyte in the sample. When the charge modifier has the same charge as at least one analyte in the sample, the charge modifier introduces a Coulombic repulsive effect with the sample(s) having the same charge (i.e., like charges repel). This repulsive effect shields the analyte(s) from interacting with the substrate material of the flow path. The selection of an appropriate charge modifier can also depend on practical limitations, for example whether a suitable silane reagent can be sourced, or if it is to be synthesized, it is can be vaporized or made to be soluble in a suitable solvent system to carry out a reaction. In addition, the stability of the resulting coating should be considered. For example, a strong base that is also a nucleophile can be problematic because it can self catalyze its hydrolytic degradation.
- In addition to introducing a Coulombic repulsive effect with the sample(s) having the same charge, charge modifiers can also facilitate multidimensional chromatography by strongly retaining a class of analytes by a retention mechanism that is orthogonal to that of an implemented liquid chromatography column. For example, analytes adsorb to a flow path component having an alkylsilyl coating with a charge modifier (e.g., a frit at the entrance of a chromatography column), are eluted to a downstream chromatography column in a gradient or set of discrete mobile phase changes and secondary gradients across the packed bed of the chromatography column are thereafter performed.
- The charge modifier can be, for example, any one or more of the following charge modifiers: a quaternary amine,
- Z is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I. Therefore, the charge modifier is covalently bound to the alkylsilyl coating of Formula I by a silyl ether moiety. A corresponding charge modifying reagent can be used to obtain the charge modifier of the final coating product, for example, the charge modifying reagent can be trimethoxy silyl propyl methyl phosphonate or N,N-(diethylaminopropyl) trimethoxysilane, or 2-(4-pyridylethyl)triethoxysilane.
- In some embodiments, a single charge modifier is applied to the vapor deposited alkylsilyl (Formula I). In other embodiments, multiple charge modifiers are applied to the vapor deposited alkylsilyl (Formula I). The multiple charge modifiers can be the same charge modifier applied at multiple X positions of Formula I. Alternatively, the multiple charge modifiers can be different charge modifiers applied at different X positions of Formula I.
- In some embodiments, a vapor deposition alylsilyl coating can be deliberately doped with a charged surface modifier (RC), for example, the charged surface modifiers of U.S. Pat. No. 10,159,911 issued Dec. 25, 2018 and entitled “High Purity Chromatographic Materials Comprising an Ionizable Modifier,” the entire contents of which is hereby incorporated by reference.
- The charge modifier (RC) can have a surface coverage of between about 0.01 μmol/m2 to about 10 μmol/m2. In some embodiments, the charge modifier (RC) has a surface coverage of between about 0.02 μmol/m2 to about 1 μmol/m2. In some embodiment, the the charge modifier (RC) has a surface coverage of between about 0.1 μmol/m2 to about 1 μmol/m2.
- An example of an active coating having an alkylsilyl coating of Formula I with a charge modifier (RC) that can result from
coating # 3 ofFIG. 2 is shown below. Although the final alkylsilyl coating shown below has multiple points for other charge modifiers (RC) those points could also be C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, or a halo, as described herein. In addition, although the final alkylsilyl coating shown below has multiple points for other charge modifiers (RC) those points could also be a hydrophobicity modifier (RB) and/or chelators or crown ethers. The charge modifiers (RC) shown below can also be other points of attachment to the surface of the chromatographic flow path, i.e., RA. - In some embodiments, the alkysilyl coating with a charge modifier (RC) is combined with a hydrophobicity modifier (RB). The hydrophobicity modifier can have a net neutral charge. Encompassed within the reagent choices of a hydrophobicity modifier are zwitterionic modifiers, such as carboxy- and sulfobetaine reagents. A zwitterionic modifier affords a macroscopically, net neutral surface, but also lends microscopic Coulombic effects that can be repulsive to a wide range of analytes, including those with diverse charge characteristics.
- The hydrophobicity modifier (RB) can have a surface coverage between about 0.01 0.01 μmol/m2 to about 10 μmol/m2. In some embodiments, the hydrophobicity modifier (RB) has a surface coverage of between about 0.03 μmol/m2 to about 0.9 μmol/m2. In some embodiments, the hydrophobicity modifier (RB) has a surface coverage of between about 0.5 μmol/m2 to about 3 μmol/m2.
- The hydrophobicity modifier (RB) is attached to Formula I by a silyl ether moiety and has a composition selected the from one or more of the following:
- Z is independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, halo, or an attachment point to Formula I. At least one Z is the attachment point to Formula I. Therefore, the hydrophobicity modifier is covalently bound to the alkylsilyl coating of Formula I by a silyl ether moiety. A corresponding hydrophobicity modifying reagent can be used to obtain the charge modifier of the final coating product, for example, the charge modifying reagent can be (3-glycidyloxypropyl)trimethoxysilane, hydrolyzed (3-glycidyloxypropyl)trimethoxysilane, n-decyltrichlorosilane, or N-(3-trimethoxysilylpropyl)gluconamide.
- Several coatings corresponding to exemplary embodiments of the technology are shown in
FIG. 2 . These coatings include coatings having only a charge modifier (RC), for examplecoating #s 1 and 3, as well as coatings having both a charge modifier (RC) and a hydrophobicity modifier (RB), for examplecoating #s 2, 4, and 5. - Hydrophobicity modifiers, in combination with the charge modifiers, can be used to add a subtle, but well controlled secondary interaction. Molecules that might otherwise co-elute as a consequence of having near identical hydrophobicities can pass through, for example a frit coated with coating #4 shown in
FIG. 2 , where the molecule can experience subtle ion exchange partitioning when a gradient between water and acetonitrile based mobile phases are applied with acid modifiers of varying acidity, hydrophobicity, and ion pairing strength. Formic acid modified mobile phases are particularly useful in this regard as it does not attenuate electrostatic effects. This can be particularly useful when separating, for example, peptides, assays for citric acid cycle metabolites and glycans. Hydrophobicity modifiers, in combination with the charge modifiers, can also be used in hydrophilic interaction chromatography. - An example of an active coating having an alkylsilyl coating of Formula I with a charge modifier (RC) and a hydrophobicity modifier (RB) that can result from coating #4 of
FIG. 2 is shown below. Although the resulting coating shown below has multiple charge modifiers (RC) any or all of those points could be a hydrophobicity modifier (RB) or C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, or a halo or chelators or crown ethers, as described herein. In some embodiments, the charge modifier (RC) and a hydrophobicity modifier (RB) need not be directly linked, for example, the charge modifier (RC) and a hydrophobicity modifier (RB) can be connected through one or more bridging silicon moieties with Y (as defined herein) chemical compositions. - In some embodiments, the alkysilyl coating with a charge modifier (RC) is combined with an ion scavenging ligand, for example a chelator or crown ether. The chelator can be, for example, ethylenediaminetetraacetic acid or etidronic acid. The crown ether can be, for example, 18-crown-6, 12-crown-4, 15-crown-5, dibenzo-18-crown-6, or diaza-18-crown-6.
- The chelators and crown ethers can be attached covalently to a silanized/alkylsilyl coating, either through direct covalent attachment or through the use of secondary linker moieties. The chelators and crown ethers can scavenge ions, for example, Ca2+, Fe3+ and/or K+ that can be present in mobile phases, flow paths, and systems, which result in undesired gas phase ion adducts and cause the fouling and decommissioning of the mass spectrometer. For example, the chelator or crown ether can pull metal ions out of the mobile phase to improve MS spectra. Often, even MS grade mobile phases will contain trace amounts of metal ions, such as sodium and potassium, and it is common for the quality of the mass spectra to suffer, as a result. A 50 ppb concentration of potassium can yield a 2 to 10% relative intensity of potassiated adduct ion. An active coating such as this can sequester these metal ions, ensuring they are not present in the chromatographic effluent upon ionization. In turn, mass spectra can be obtained with ion adduct signals below 2% relative intensity even when mobile phases with questionable purity are employed. This type of coating can be used prior to an injector and post column in the flow path.
- In some embodiments, the chelator and crown ethers can be combined directly with the alkylsilyl coating of Formula I, without a charge modifier being present.
- In some embodiments, the chelators and crown ethers can also be used in conjunction with the hydrophobicity modifiers described herein. In some embodiments, the chelators and crown ethers can be used in conjunction with both the charge modifiers and hydrophobicity modifiers described herein.
- Therefore, when chelators and/or crown ethers are used as an active coating, a chromatographic device for separating analytes in a sample includes a sample injector having a sample injection needle for injecting the sample into the mobile phase, a sample reservoir container in fluid communication with the sample injector, a chromatography column downstream of the sample injector, the chromatography column having fluid connectors, and fluid conduits connecting the sample injector and the chromatography column. Interior surfaces of the fluid conduits, sample injector, sample reservoir container, and chromatography column form a fluidic flow path having wetted surfaces. At least a portion of the wetted surfaces of the fluidic flow path are coated with an alkylsilyl coating having the Formula I:
- wherein each X is independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, RB, RC, RD and halo. RA represents a point of attachment to the interior surfaces of the fluidic system and at least one X is ORA. RB is absent or represents a hydrophobicity modifier. RC is absent or represents a charge modifier. RD represents a chelator, or a crown ether, and at least one X is RD. Y is a bridging moiety selected from (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20-, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-.
- In some embodiments, a chromatographic device for separating analytes in a sample includes a mobile phase reservoir, a mobile phase pump in communication with the mobile phase reservoir, a mobile phase inlet line have a first end in communication with the mobile phase reservoir and a second end in communication with the mobile phase pump, and a sinker at the first end of the mobile phase inlet line. Interior surfaces of the mobile phase reservoir, the mobile phase pump and the mobile phase inlet line form a fluidic flow path having wetted surfaces. Exterior surfaces of the sinker also have wetted surfaces, which are in contact with the mobile phase. At least a portion of the wetted surfaces in contact with the mobile phase are coated with an alkylsilyl coating having the Formula I:
- wherein each X is independently selected from C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, RB, RC, RD, RE, and halo. RA represents a point of attachment to the interior surfaces of the fluidic system and at least one X is ORA. RB is absent or represents a hydrophobicity modifier. RC is absent or represents a charge modifier. RD is absent or represents a chelator, or a crown ether. RE is a bacteriostatic moiety, and at least one X is RE. Y is a bridging moiety selected from (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20-, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-.
- In some embodiments, the bacteriostatic moiety is a zwitterion. The zwitterionic coatings can be prepared by silanization with bis(trichlorosilyl)ethane followed by derivatization with N,N-(diethylaminopropyl)trimethoxysilane and subsequent reactions with chloro or bromo alkylcarboxylic acids. In some embodiments, the bacteriostatic moiety is a quaternary amine.
- In some embodiments the bacteriostatic coating is applied to all components within the flow path including inlet filters, inlet mobile phase lines, pumps, transfer lines, sample syringes, frits and mobile phase containers (see, e.g.,
FIG. 1 ) to provide systemic protection against bacterial growth and premature column failure. - The bacteriostatic moiety can be used alone, or in conjunction with a charge modifier, a hydrophobicity modifier and/or a chelator or crown ether.
- In some embodiments, surfactants can be used as an active coating to solubilize proteins, including hydrophobic membrane proteins, and provide a denaturing environment that facilitates enzyme reactions, such as proteolysis and glycan release.
- A chromatographic device for separating analytes in a sample includes a sample injector having a sample injection needle for injecting the sample into the mobile phase, a sample reservoir container in fluid communication with the sample injector, a chromatography column downstream of the sample injector, the chromatography column having fluid connectors, and fluid conduits connecting the sample injector and the chromatography column. Interior surfaces of the fluid conduits, sample injector, sample reservoir container, and chromatography column form a fluidic flow path having wetted surfaces. At least a portion of the wetted surfaces of the fluidic flow path are coated with an alkylsilyl coating having the Formula I:
- wherein each X is independently selected from (C1-C6)alkoxy, —NH(C1-C6)alkyl, —N((C1-C6)alkyl)2, OH, ORA, RB, RC, RD, RE, RF, and halo. RA represents a point of attachment to the interior surfaces of the fluidic system and at least one X is ORA. RB is absent or represents a hydrophobicity modifier. RC is absent or represents a charge modifier. RD is absent or represents a chelator, or a crown ether. RE is absent or represents a bacteriostatic moiety. RF represents a surfactant, and at least one X is RF. Y is a bridging moiety selected from (C1-C20)alkyl, —O[(CH2)2O]1-20—, —(C1-C10)[NH(CO)NH(C1-C10)]1-20-, or —(C1-C10)[alkylphenyl(C1-C10)alkyl]1-20-.
- In some embodiments, the surfactant (RF) is sodium dodecyl sulfate, zwittergent 3-10 (Decyldimethylammonio)propanesulfonate, sodium deoxycholate, hexadecyl trimethyl ammonium bromide, triton, polysorbate, or a combination thereof.
- Methods
- The devices and alkylsilyl coatings described herein can be used in chromatographic methods to separate analytes in a sample. In general, the method includes introducing a sample including the analytes into a chromatographic system (e.g., a liquid chromatography system). The chromatographic system includes a flow path disposed in an interior of the chromatographic system where at least a portion of the flow path has an active coating. The chromatographic system also includes a chromatographic column that has a stationary phase material in an interior of the chromatographic column that facilitates separation of the analytes in the sample through interaction with at least one analyte in the sample. For example, the chromatographic system can be the chromatographic system of
FIG. 1 as described in detail herein. - The active coating is selected to interact with at least one analyte in the sample. The interaction can be through repulsive forces, a secondary interaction, or a retention mechanism distinct from the interaction with the stationary phase material. The secondary interaction can be ion exchange partitioning.
- The analyte and the active coating can be negatively charged. The analyte and the active coating can be positively charged. When the analyte and the active coating both have the same charge, the active coating repels the analyte and shields the analyte from interacting with the substrate (e.g., a metal chromatographic column or frit).
- The active coating can be applied to the flow path via vapor deposition. The active coating can be applied to a frit. The frit can be positioned at an inlet, an outlet or at both an inlet and outlet of the chromatographic column (see
FIG. 1 ). The active coating can be any of the coating described herein. - The technology includes a method of separating a sample comprising an anionic compound. The method includes introducing the sample comprising the anionic compound to a fluidic system including a flow path disposed in an interior of the fluidic system wherein at least a portion of the flow path includes an alkylsilyl coating of Formula I (as described herein) with a negatively-charged modifier. The sample is eluted through the fluidic system and the anionic compound is repelled by a negatively-charged modifier. The method also includes isolating the anionic compound. The anionic compound can be, for example, a nucleic acid or an oligonucleotide. The alkylsilyl coating can be, for example, coating #1 shown in
FIG. 2 (bis(trichlorosilyl) ethane followed by trimethoxy silyl propyl methyl phosphonate). This method can be used to analyze nucleic acids or oligonucleotides at a pH above their isoelectric point. - Similarly, the method can be applied to samples comprising cations where the alkylsilyl coating of Formula I (as described herein) has a positively-charged modifier.
- The technology also includes a method of separating a sample comprising peptides. The method includes introducing the sample comprising the peptides into a chromatography column having a hydrophobic stationary phase disposed within the chromatography column and a frit at an outlet of the chromatography column. In some embodiments, the hydrophobic stationary phase is a bridged ethylene hybrid C18 stationary phase. The frit is coated with an alkylsilyl coating of Formula I (as described herein) where the alkylsilyl coating has both a charge modifier and a hydrophobicity modifier. The charge modifier has a surface coverage of between about 0.03 μmol/m2 to about 0.9 μmol/m2 and the hydrophobicity modifier has a surface coverage of between about 0.5 μmol/m2 to about 3 μmol/m2. The method also includes eluting the sample through the chromatography column and isolating the peptides.
- The charge modifier can be N,N-(diethylaminopropyl)silyl and the hydrophobicity modifier can be n-decyl silyl (i.e., coating #4 in
FIG. 2 ). In some embodiments, the charge modifier, N,N-(diethylaminopropyl)silyl, accounts for 10% of the surface coverage and the hydrophobicity modifier, n-decyl silyl, accounds for 90% of the surface coverage. Other ratios and percentages of surface coverage of the charge modifier and hydrophobicity modifier can be used. - The peptides can be an Asp and iso ASP isomeric peptide pair. The method can also include partitioning the Asp and iso ASP isomeric peptide pair on the coated frit.
- The sample can include trypsinized immunoglobulin. In some embodiments, the trypsinized immunoglobulin is trastuzumab.
- The technology also includes a method of separating a sample comprising proteins. The method includes introducing the sample comprising proteins into a chromatography column having a hydrophobic stationary phase disposed within the chromatography column and a frit at an inlet of the chromatography column. In some embodiments, the hydrophobic stationary phase is a bridged ethylene hybrid C4 stationary phase. The frit is coated with an alkylsilyl coating of Formula I (as described herein) having a charge modifier with a surface coverage of between about about 0.1 μmol/m2 to about 3 μmol/m2. In some embodiments, the charge modifier is silyl propyl methyl phosphonate (i.e., coating #1 in
FIG. 2 ). The alkylsilyl coating used in this method does not have a hydrophobicity modifier. The method also includes eluting the sample through the chromatography column and isolating the proteins. - The method can also include flowing a mobile phase having an ionic strength through the chromatography column such that the proteins are retained on the frit. The ionic strength of the mobile phase can be increased to displace a portion of the proteins from the frit. The method also includes eluting the displaced proteins through the chromatography column.
- In another embodiment, the method includes coating flow paths prior to analyte introduction with a coating having a bactiostatic moiety as described herein. The flow path includes, for example, a mobile phase reservoir, mobile phase inlet lines, mobile phase pump, and a sinker. In some embodiments, the bacteriostatic coating in included along portions or the entirety of the flow path of a chromatographic system.
- In some embodiments, the method includes coating at least a portion of a flow path of a chromatographic system with a coating having a surfactant, as described herein.
- Kits
- The technology also includes kits. The kits include a chromatographic components, for example, a chromatographic column, that has been coated with an alkylsilyl coating of Formula I, as described above. Other components can be provided in the kit that can also include the coatings described herein, for example, tubing, frits, and/or connectors. The kit can also include instructions for separating analytes, for example, biomolecules, proteins, glycans, peptides, oligonucleotides, pesticides, bisphosphonic acids, anionic or cationic compounds, and zwitterions like amino acids and neurotransmitters.
- This is an example of an analyte-specific repulsive coating and an apparatus for the analysis of oligonucleotides. An active coating can be designed such that it bears the same charge as an analyte of interest. A coating devised for such an application is described in
FIG. 2 (Coating #1). This coating can be constructed through silanization with bis(trichlorosilyl)ethane followed by trimethoxy silyl propyl methyl phosphonate. Once applied to the needle, column housing, frits and pre- and post-column tubing (see, e.g.,FIG. 1 ), this coating yields a flow path in which all surfaces actively repel anionic compounds. In practice, this flow path can confer an LC system that could be dedicated to the separation of certain analytes, such as nucleic acids or oligonucleotides. These types of analytes are polyanions and notoriously prone to adsorbing onto metal surfaces. It can be predicted that opposite charge compounds can adsorb to the coating in time and with routine sample injections. Nevertheless, it is believed that these adsorbed molecules will equilibrate to afford a surface that itself also exhibits low bind properties for the oligonucleotides. Because of this dynamic equilibrium, the surface charge must be deliberately selected and optimized. - This is an example of a selectivity enhancing coated flow path component and method for the analysis of citric acid cycle metabolites and Asp/iso Asp peptide isomers. An active coating can be employed to enhance the selectivity of a separation. Many chromatographic applications are challenged to produce a separation between critical components, such as the acids of a citric acid cycle panel or the Asp/Iso Asp peptide isomers in an immunoglobulin proteolytic digest. To that end, a charge-modified, active coating can be combined with certain chromatographic modes and columns to achieve more effective, tailored separations. In one aspect, a surface modified with a basic, charge bearing moiety would be ideal for this application, such as a coating formed via silanization with bis(trichlorosilyl)ethane followed by a low coverage of N,N-(diethylaminopropyl)trimethoxysilane and high coverage of n-decyl trichlorosilane (i.e.,
FIG. 2 , Coating #4). In which case, ideal coverage of N,N-(diethylaminopropyl)trimethoxysilane would correspond to 0.03 to 0.9 μmol/m2 and ideal coverage for n-decyl trichlorosilane would correspond to 0.5 to 3 μmol/m2. - A high surface area component of the flow path can be selected for use as a selectivity enhancer, lest its surface area be too insignificant to make a difference to the retentivity or selectivity of the overall separation apparatus. For this reason, the frit of a liquid chromatography (LC) column housing can be modified to exhibit an active coating and advantageously used as a selectivity enhancer to add a subtle, yet well controlled secondary interaction. In one exemplary embodiment, a 0.2 μm porosity stainless steel frit is modified with Coating #4 of
FIG. 2 and used in the outlet of an ACQUITY® UPLC®Peptide BEH C18 130 Å 1.7 μm 2.1×150 mm column (commercially available from Waters Technologies Corporation, Milford, Mass.). Optionally, this coated frit can be constructed into a column format with special design features amenable to the swapping and replacement of the high surface area selectivity enhancer. A sample of trypsinized immunoglobulin, such as trastuzumab, gets loaded onto the column and then a gradient between water and acetonitrile based mobile phases is applied. Acid modifiers of varying acidity, hydrophobicity and ion pairing strength can be applied, though formic acid modified mobile phases are particularly attractive in that they do not attenuate electrostatic effects. Peptides that might co-elute as a consequence of having near identical hydrophobicities will pass through the selectivity enhancer wherein they will experience subtle ion exchange partitioning. In the case of an Asp and iso Asp isomeric peptide pair, the iso Asp containing species will be partitioned and thus be retained more extensively than the Asp containing species, given that an iso Asp residue is slightly more acidic (pKa 3.1 versus 3.9). This method is equally applicable to numerous other types of separations, including assays for citric acid cycle metabolites and glycans. In other embodiments, an acidic, cation exchange selectivity enhancer can be employed. In yet other embodiments, the selectivity enhancer can be used with hydrophilic interaction chromatography (HILIC). - This is an example of an active coating with orthogonal retentivity to perform multidimensional chromatography. An active coating can also be used to facilitate multidimensional chromatography. Like with the selectivity enhancer, a high surface area flow component, like a frit, makes for a preferred substrate. Unlike the selectivity enhancer, it is intended for this active coating to strongly retain a class of analytes by a retention mechanism that is orthogonal to that of the implemented LC column. Though this coating can be implemented at any location in the flow path, it is advantageous to consider it being incorporated at the head (inlet) of the column. Analytes adsorb to this flow path component, are eluted to a downstream LC column in a gradient or set of discrete mobile phase changes and secondary gradients across the packed bed of the LC column are thereafter performed. In one aspect, a surface modified with a strongly acidic, charge bearing moiety would be ideal for this application, such as a coating formed via silanization with bis(trichlorosilyl)ethane followed by trimethoxy silyl propyl methyl phosphonate. For this application, ideal coverage for trimethoxy silyl propyl methyl phosphonate would correspond to 0.1 to 3 μmol/m2.
- For instance, in one exemplary embodiment, a 0.2 μm porosity stainless steel frit is modified with a version of Coating #1 of
FIG. 2 having a high coverage of trimethoxy silyl propyl methyl phosphonate (2 μmol/m2) and is used in the inlet of an ACQUITY® UPLC®Peptide BEH C18 130 Å 1.7 μm 2.1×150 mm column (commercially available from Waters Technologies Corporation, Milford, Mass.). A proteolyzed protein sample gets loaded onto the column under aqueous, low ionic strength conditions. By way of cation exchange, the peptides are thus retained on the inlet frit. An increase in mobile phase ionic strength can then be employed to displace a subset of the peptides (the least basic) onto the packed bed of the LC column. A gradient between water and acetonitrile is thereafter applied to elute the displaced peptides and thereby obtain a second dimension chromatogram. This process is continued with steps of increasing ionic strength until the entirety of the sample is profiled. Again, this method is equally applicable to numerous other types of separations and analytes, not only peptides and proteolyzed proteins. It is also applicable to use with a HILIC LC column. - This is an example of an active coating with ion scavenging ligands. A coated flow path component can be modified to bear ion scavenging ligands, such as chelators or crown ethers. For liquid chromatography to be most effective when hyphenated with mass spectrometry, it is necessary for the mobile phases, flow paths and systems to be free of non-volatile ions that when present can yield undesired gas phase ion adducts, if not cause the fouling and decommissioning of the mass spectrometer.
- A number of chemical compounds show a capacity to sequester metal ions, whether they be alkali, alkaline earth and transition metals. Chelators, such as ethylenediaminetetraacetic acid and etidronic acid, are ubiquitously used in solutions to scavenge Ca2+ and Fe3+. In addition, crown ethers can be used to selectively coordinate certain cations with high affinity. 18-crown-6, for instance, is widely recognized for its high affinity for potassium (K+) ions. In some aspects of this invention, these ligands can be attached covalently to a silanized/alkylsilyl coating, either through direct covalent attachment or through the use of secondary linker moieties.
- In one example, a 0.2 μm porosity stainless steel frit is modified with bis(trichlorosilyl)ethane coating, which is then subsequently derivatized with a crown ether, including but not limited to 18-crown-6, 12-crown-4, 15-crown-5, dibenzo-18-crown-6, and diaza-18-crown-6. This frit can be used as the outlet of an LC column or in a separate vessel to scavenge for impurity metal cations that might be present in mobile phases or leaching from an instrument flow path. In using this invention, it would be possible to minimize the formation of sodium and potassium analyte adduct ions that are otherwise regularly encountered in the positive ion mode electrospray MS spectra of various types of molecules, including by not limited to peptides, glycans, and proteins
- This is an example of an active coating with bacteriostatic properties. In liquid chromatography, mobile phases with pH values in the physiological range that do not contain organic solvent will readily support microbial growth. Although it is recommended that mobile phases be changed frequently to prevent the buildup of bacteria on surfaces, especially in aqueous mobile phases, customers typically do not do this in practice. Microbial contamination of the LC system can cause column fouling, resulting in an unacceptable separation and will result in premature failure of the column.
- An active coating devised to be a bacteriostatic agent represents an ideal solution because the agents can be applied to all components within the flow path including inlet filters, inlet mobile phase lines, pumps, transfer lines, sample syringes, frits and mobile phase containers (see, e.g.,
FIG. 1 ) to provide systemic protection against bacterial growth and premature column failure. - In one embodiment, zwitterionic coatings can be prepared by silanization with bis(trichlorosilyl)ethane followed by derivatization with N,N-(diethylaminopropyl)trimethoxysilane and subsequent reactions with chloro or bromo alkylcarboxylic acids. Quaternary amines have been shown to have potent antimicrobial activity and can be applied to the surface of frits or degasser lines to reduce or eliminate growth thus avoiding premature column failure. While not limited to theory, it is believed that quaternary amine and zwitterion containing active coatings disrupt the formation lipid bilayers and thereby interfere in an integral mechanism of biological growth. In some embodiments, bacteriostatic coatings are employed in regions prior to analyte injection, for example, sinkers and mobile phase inlet lines.
- This is an example of an active coating with surfactants. Surfactants are used to solubilize proteins, including hydrophobic membrane proteins, and provide a denaturing environment that facilitates enzyme reactions, such as proteolysis and glycan release. In practice, the use of ionic surfactants in LC/MS analysis is discouraged due to the reduction of analyte signal observed because of the highly charged nature of the surfactant. This problem can be alleviated by the use of surfactants that are tethered to a device (or coated on a device) and not prone to release into the MS system. This MS friendly solution would enable single step online protein digestion in a system where the surfactant is tethered and cannot be released into the MS instrument coupled to an immobilized trypsin or other proteolytic enzyme column. Surfactant moieties with desirable properties include, but are not limited to, sodium dodecyl sulfate, zwittergent 3-10 (Decyldimethylammonio)propanesulfonate, sodium deoxycholate, hexadecyl trimethyl ammonium bromide, triton and polysorbate. In an alternative embodiment, chaotropic moieties can be incorporated into the active coating and can consist of chemical structures with chemical similarity to guanidine and urea. In each of these examples, the active coating will induce the denaturation of a protein analyte through manipulating its entropically driven, hydration based folding.
- While this disclosure has been particularly shown and described with reference to example embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the technology encompassed by the appended claims.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/800,454 US11994499B2 (en) | 2019-02-27 | 2020-02-25 | Coated flow path components for chromatographic effects |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962811029P | 2019-02-27 | 2019-02-27 | |
US16/800,454 US11994499B2 (en) | 2019-02-27 | 2020-02-25 | Coated flow path components for chromatographic effects |
Publications (2)
Publication Number | Publication Date |
---|---|
US20200271629A1 true US20200271629A1 (en) | 2020-08-27 |
US11994499B2 US11994499B2 (en) | 2024-05-28 |
Family
ID=69784485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/800,454 Active 2040-02-28 US11994499B2 (en) | 2019-02-27 | 2020-02-25 | Coated flow path components for chromatographic effects |
Country Status (4)
Country | Link |
---|---|
US (1) | US11994499B2 (en) |
EP (1) | EP3930868B1 (en) |
CN (1) | CN113507972B (en) |
WO (1) | WO2020174402A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11918936B2 (en) | 2020-01-17 | 2024-03-05 | Waters Technologies Corporation | Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140376081A1 (en) * | 2013-06-24 | 2014-12-25 | Seiko Epson Corporation | Electrophoretic particles, electrophoretic dispersion liquid, display sheet, display device, and electronic equipment |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4029583A (en) * | 1975-02-28 | 1977-06-14 | Purdue Research Foundation | Chromatographic supports and methods and apparatus for preparing the same |
US4293415A (en) * | 1979-04-27 | 1981-10-06 | Hewlett-Packard Company | Silica chromatographic column |
US5374755A (en) * | 1992-07-17 | 1994-12-20 | Millipore Corporation | Liquid chromatography stationary phases with reduced silanol interactions |
AU8261098A (en) * | 1997-06-24 | 1999-01-04 | University Of Wyoming | Method and apparatus for detection of a controlled substance |
US20030138973A1 (en) * | 1998-07-14 | 2003-07-24 | Peter Wagner | Microdevices for screening biomolecules |
US6277489B1 (en) * | 1998-12-04 | 2001-08-21 | The Regents Of The University Of California | Support for high performance affinity chromatography and other uses |
WO2002059591A1 (en) * | 2001-01-24 | 2002-08-01 | University Of South Florida | Sol-gel open tubular ods columns with charged inner surface for capillary electrochromatography |
US20050051489A1 (en) * | 2003-08-20 | 2005-03-10 | California Institute Of Technology | IC-processed polymer nano-liquid chromatography system on-a-chip and method of making it |
CA2546898C (en) * | 2003-11-20 | 2016-11-22 | Sigma-Aldrich Co. | Polysilazane thermosetting polymers for use in chromatographic systems and applications |
US20060175238A1 (en) * | 2005-02-10 | 2006-08-10 | Lautamo Roy M | Deactivated surfaces for chromatographic separations and methods of making and using the same |
US20090206034A1 (en) * | 2006-03-29 | 2009-08-20 | Osakazu Nakajima | Modified silica gel and use thereof |
US20090203146A1 (en) * | 2006-06-21 | 2009-08-13 | Northeastern University | Narrow bore layer open tube capillary column and uses thereof |
US7914460B2 (en) * | 2006-08-15 | 2011-03-29 | University Of Florida Research Foundation, Inc. | Condensate glucose analyzer |
JP5600434B2 (en) * | 2007-04-27 | 2014-10-01 | アークレイ株式会社 | Analysis chip and analyzer |
JP2010527003A (en) * | 2007-05-08 | 2010-08-05 | ウオーターズ・テクノロジーズ・コーポレイシヨン | Chromatographic and electrophoretic separation media and equipment |
EP2304423B1 (en) * | 2008-07-18 | 2019-02-20 | Waters Technologies Corporation | Devices having an inert surface and methods of making same |
WO2010013698A1 (en) * | 2008-08-01 | 2010-02-04 | 株式会社資生堂 | Sample injection device, sample injection method, and liquid chromatography device |
WO2010096200A2 (en) * | 2009-02-23 | 2010-08-26 | Restek Corporation | Gas chromatography inlet liner having at least one indicator |
CN105126792A (en) * | 2009-08-04 | 2015-12-09 | 沃特世科技公司 | High purity chromatrographic materials comprising an ionizable modifier |
US10159911B2 (en) | 2009-08-04 | 2018-12-25 | Waters Technologies Corporation | High purity chromatographic materials comprising an ionizable modifier |
GB2486679B (en) * | 2010-12-22 | 2017-10-04 | Agilent Technologies Inc | Dual-material approach for high pressure bioinert flow path components |
US9120846B2 (en) * | 2011-10-03 | 2015-09-01 | Sachem, Inc. | Neutral zwitterionic displacer molecules for hydrophobic displacement chromatography |
US9925521B2 (en) * | 2012-05-15 | 2018-03-27 | Waters Technologies Corporation | Chromatographic materials |
GB2502272B (en) * | 2012-05-21 | 2014-08-20 | Thermo Electron Mfg Ltd | Method and apparatus for reaction chromatography |
US20150024152A1 (en) * | 2013-07-19 | 2015-01-22 | Agilent Technologies, Inc. | Metal components with inert vapor phase coating on internal surfaces |
WO2016114850A1 (en) * | 2015-01-14 | 2016-07-21 | Agilent Technologies, Inc. | Components with an atomic layer deposition coating and methods of producing the same |
WO2017040623A1 (en) | 2015-09-01 | 2017-03-09 | Silcotek Corp. | Thermal chemical vapor deposition coating |
CN109154604B (en) * | 2016-04-24 | 2023-07-21 | 沃特世科技公司 | Charged surface reversed phase chromatography material method for analysis of glycans modified with amphiphilic strong basic moieties |
US11709155B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
US11959894B2 (en) | 2018-02-23 | 2024-04-16 | Silcotek Corp | Liquid chromatography technique |
-
2020
- 2020-02-25 CN CN202080017473.6A patent/CN113507972B/en active Active
- 2020-02-25 US US16/800,454 patent/US11994499B2/en active Active
- 2020-02-25 EP EP20710599.0A patent/EP3930868B1/en active Active
- 2020-02-25 WO PCT/IB2020/051612 patent/WO2020174402A1/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140376081A1 (en) * | 2013-06-24 | 2014-12-25 | Seiko Epson Corporation | Electrophoretic particles, electrophoretic dispersion liquid, display sheet, display device, and electronic equipment |
Also Published As
Publication number | Publication date |
---|---|
WO2020174402A1 (en) | 2020-09-03 |
EP3930868B1 (en) | 2024-07-17 |
CN113507972A (en) | 2021-10-15 |
US11994499B2 (en) | 2024-05-28 |
EP3930868A1 (en) | 2022-01-05 |
CN113507972B (en) | 2023-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11709155B2 (en) | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes | |
US20200215457A1 (en) | Use of vapor deposition coated flow paths for improved analytical analysis | |
EP1817109B1 (en) | Mixed-modal anion-exchange type separation material | |
US5277813A (en) | Shielded stationary phases | |
JP2005529335A (en) | Systems and methods for extracting biomolecules as solid phases using open channels | |
EP3431481B1 (en) | Methods and devices for performing phospholipid separation | |
CN112955239B (en) | Liquid chromatography/mass spectrometry method for polar molecule analysis | |
US20200269157A1 (en) | Chromatographic seal and coated flow paths for minimizing analyte adsorption | |
US20230393104A1 (en) | Use of vapor deposition coated flow paths for improved analytical analysis | |
US11994499B2 (en) | Coated flow path components for chromatographic effects | |
WO2022079695A1 (en) | Improved device including a hydrophilic, non-ionic coating for size exclusion chromatography | |
US20210164094A1 (en) | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes | |
EP3821238B1 (en) | Chromatographic system and method for trap-elute mixed mode chromatography | |
EP1265067A1 (en) | Column packing for chromatography | |
US12048926B2 (en) | Coatings with immobilized affinity ligands and enzymes and use thereof in liquid chromatography assays | |
WO2014061723A1 (en) | Separation medium, column employing said separation medium, liquid chromatograph equipped with said column, and process for producing said separation medium | |
US20210223217A1 (en) | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes | |
US20240226845A1 (en) | Dipodal silane bonded sorbents for solid phase extraction and use thereof for oligonucleotide extraction | |
US20240189740A1 (en) | Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding | |
EP4217730A1 (en) | Chromatographic hardware improvements for the separation of reactive molecules | |
WO2017203683A1 (en) | Separation medium and method for producing same, separation column, and liquid chromatograph using said separation column |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
AS | Assignment |
Owner name: WATERS TECHNOLOGIES CORPORATION, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LAUBER, MATTHEW A.;GILAR, MARTIN;DELANO, MATHEW H.;AND OTHERS;SIGNING DATES FROM 20190227 TO 20190304;REEL/FRAME:052146/0951 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
ZAAB | Notice of allowance mailed |
Free format text: ORIGINAL CODE: MN/=. |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |